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ABSTRACT 
OF MICE AND SIGMA: 
CONFERRED ANTIBIOTIC RESISTANCE IN THE 
SALMONELLA ENTERICA SEROVAR TYPHIMURIUM MURINE MODEL 
Rena Margaret Wallen 
April 6, 2012 
Salmonella enterica serovar Typhimurium is an enteric pathogen capable of infecting 
a wide range of hosts. The manner in which this pathogen is able to interact with its 
host is difficult to define, as is the case with most microbes. Through the use of 
alternate sigma factors and other regulatory processes, S. Typhimurium is able to 
invade host cells to establish systemic infections, and survive the assaults of the host 
immune system. While most strains of S. Typhimurium are typically ampicillin 
sensitive, within the host, survival inside host cells may provide an escape from 
many antibiotics. Previous research demonstrated that co-culture with ampicillin 
resistant strains of Escherichia coli is able to provide protection for sensitive S. 
Typhimurium. The current study was an attempt to model this relationship within 
the host. While S. Typhimurium was able to grow within murine hosts in the 
presence of ampicillin, it is unclear whether this resistance is from coinfection with 
a resistant strain of E. coli or from the ability of S. Typhimurium to avoid destruction 
by antibiotics by invading host cells. 
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The emergence of antibiotic resistance in bacteria has caused many concerns 
in the sanitation and health care industries. Most of this resistance seems to be the 
result of transfer of genetic information between the same or closely related species. 
However, this may not be the only way that antibiotic susceptible bacteria are able 
to survive in the presence of bactericidal agents. Previous work has demonstrated 
that bacteria that do not possess genetic information to produce enzymes conferring 
resistance may be able to survive in the presence of other bacteria that do, even in 
the presence of lethal dosages of antibiotics. 
The specific antibiotic examined in these studies was ampicillin. Ampicillin is 
a member of the p-Iactam family of antibiotics that includes amoxicillin and 
penicillin. This family of antibiotics binds to and prevents the action of 
transpeptidases that are important in constructing the peptidoglycan layer of the 
bacterial cell well [1]. Blocking the activity of these transpeptidases renders the 
bacterium unable to complete its cell wall and results in a loss of osmotic stability 
and eventually cell death [1]. Sensitivity to this mechanism of action requires the 
bacteria to be growing and making new cell wall elements. p-Iactam antibiotics are 
therefore only effective against dividing cells, i.e., not those in stationary phase that 
are not rearranging and reforming their cell walls. 
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One way that bacteria are able to survive ampicillin treatment typically is by 
producing the enzyme ~-lactamase which modifies with the antibiotic's physical 
structure and activity. ~-lactamase cleaves the functional ring of ~-lactam 
antibiotics, rendering them unable to bind to transpeptidases and blocking the 
activity of the antibiotic. Because this mode of resistance is the production of an 
enzyme that breaks down the antibiotic, it has been theorized that bacteria 
producing ~-lactamase may be able to provide some protection for typically 
sensitive strains colonizing the same system. If this is the case, bacteria may be able 
to survive antibiotic treatment without acquiring the ability to produce the enzyme. 
In vitro studies co-culturing ampicillin resistant strains of bacteria with 
ampicillin sensitive strains in the presence of the drug has produced interesting 
results. In these studies, the ~-lactamase gene was carried on a plasmid by 
Escherichia coli. Multiple strains of ampicillin-resistant E. coli were engineered, each 
producing ~-lactamase from a plasmid introduced into the cell and each 
demonstrating resistance to high levels of ampicillin treatment. All of the resistant 
strains in these studies contained the biaTEMl gene, encoding a class A TEM-l ~­
lactamase [2]. Two types of strains were engineered, one in which the ~-lactamase 
remained inside the bacterial cell producing it and the other that was able to release 
the enzyme into the extracellular space. Six times more ~-lactamase was found in 
the media where growing cells releasing the enzyme than in those engineered to 
keep it inside [3]. Carrying the plasmid did result in some cost to the bacteria [2], as 
non-plasmid bearing bacteria of the same species were able to outcompete plasmid 
bearing bacteria in the absence of ampicillin [3]. 
2 
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However, in the presence of ampicillin, despite the metabolic cost, carrying 
the plasmid containing ~-lactamase produced a selective advantage. Moreover, in 
some cases, typically sensitive bacteria were able to survive when grown in culture 
with their resistant cousins. The same phenomenon was not observed equally 
amongst the two different types of strains. When co-cultured with the strain that 
kept the ~-lactamase within the producing cell, sensitive E.coli were unable to 
survive; however, in the presence of cells secreting ~-lactamase into the 
extracellular space, sensitive E.coli were able to survive, albeit at lower level than 
their resistant benefactors [2]. In a similar study, sensitive E. coli were able to 
survive at only about 3% of the original population when grown with E. coli 
releasing ~-lactamase [4]. A considerable amount of ~-lactamase was found in the 
media where these resistant bacteria had grown [3]. 
E. coli tend to be commensal species so antibiotic resistance does not present 
health complications to host organisms. However, species like Salmonella enterica 
serovar Typhimurium, which are typically pathogenic, may be offered the same 
protection as their commensal relatives in the presence of antibiotic resistant 
bacteria. In fact, S. typhimurium was observed to survive despite ampicillin 
treatment in the presence of E. coli releasing ~-lactamase. After an initial period of 
apparent elimination of S. Typhimurium lasting about 12 hours, survival ofthe 
pathogen was observed after 24 hours grown with ~-lactamase producing E. coli 
and continued to increase through the duration of the experiment [4]. Additionally, 
unlike the E. coli that were not protected by strains retaining ~-lactamase inside the 
producing cell, S. typhimurium when competed against such resistant E. coli strains, 
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was, able to survive at approximately the same rate as it was able to persist when ~­
lactamase was released into the extracellular space [4]. Further analysis ofthese 
competitions revealed that no transfer of genetic information had occurred nor did 
the resistant E. coli and sensitive S. typhimurium have to be grown in physical 
contact for the protection to be provided [4]. Moreover, while the ~-lactamase 
activity in this strain was confined to the producing cell, ~-lactamase was found 
within the supernatant, indicating cell lysis [4], potentially due to S. typhimurium 
activity against other bacterial strains. 
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CHAPTER 2 
IN VIVO EXPERIMENTS WITH SELECTED BACTERIAL STRAINS AND AMPICILLIN 
1. Introduction 
The current research is an attempt to model the competition between 
ampicillin resistant and sensitive strains within a host organism, specifically the 
mouse. Bacterial strains were introduced and monitored in the presence of 
antibiotic treatment to determine if similar results [4] could be observed within a 
live host. In vivo modeling provides environments not encountered within an in 
vitro setting. Inside a host, bacteria interact with host cells and any other bacteria 
present within the system. The microorganisms must compete for nutrients with 
the host as well as other bacteria, and the availability of nutrients is limited by the 
food intake of the host. In the case of the enteric bacteria, consumed food moving 
through the gastrointestinal tract presents a dynamic environment through which 
bacteria must negotiate. An attempt to model bacterial competitions within a host 
must consider these varied conditions. 
2. Materials and Methods 
2.1 Plasmids and Host Bacteria 
In these studies, E. coli strains were competed against other strains of E. coli 
and against S. Typhimurium, specifically strain 14028S. This S. Typhimurium strain 
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has a functional type three secretion system, necessary for establishing systemic 
infections, but does not carry any genetic antibiotic resistance. 
Three types of plasm ids were used to model bacterial competitions in mice, 
the same three that had been used in previous studies leading to the in vivo model. 
All of these plasmids were derivatives of pCR2.1 TO PO (Invitrogen, Carlsbad, CA) 
and were nonconjugative plasmids [3]. Two of these plasm ids were constructed by 
investigators in previous research leading to this work. The SAR plasmid, an 
acronym for Shared Antibiotic Resistance, carried a copy of the blaTEM-l gene 
attached to the 5' end of a region of DNA containing ompA and Ipp [2]. Along with 
OmpA and Lpp, ~-lactamase produced from the gene on this SAR plasmid is carried 
to the outer membrane but in theory remains attached to the cell, extending into the 
extracellular space where it is able to destroy ampicillin in the vicinity [2]. As noted 
earlier, because a substantial amount of ~-lactamase was found in the supernatant 
in which the bacterial strains were grown [3], it is likely that some portion of the ~­
lactamase is released from the cell, broken from its tether to the outermembrane, or 
released into the extracellular milieu upon lysis of the cell. 
The SLAR plasmid (Self-Limited Antibiotic Resistant) carries the same blaTEM-
1 gene but a mutation in the coding region for the signal peptide prevents the 
protein from being transported completely into the peri plasm [2]. As such, the 
protein is attached to the cytoplasmic membrane facing the periplasm, and in theory 
should only provide protection for the cell expressing the gene [2]. Both SLAR and 
SAR plasmids were introduced into E. coli 6925, a typical strain used in lab work (F-, 
relAl, rpsL254(strR), spoT1, metBl, LacZ+, E. coli Stock Center, CGSC, Yale 
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University). Without the plasmid, E. coli 6925 is sensitive to ampicillin treatment. 
These strains will be referred to as (pSAR) and (pSLAR) respectively. 
A third plasmid, (pBR322), is a commonly used CoIE1-derivative bearing the 
b/aTEM-l gene, as well as a tetracycline resistance gene [5]. B-Iactamase produced 
from this cell also remains inside the bacterial cell, not released to the extracellular 
milieu. The plasmid was originally in an E. coli Lu53 background (F-, /acI22 (LacI-), 
proC43, D(kdpC-kdpA)18, LAM-, /ysA28, rpsL139(strR),g/pR7(glpn)?, g/pR8(glpc), 
rha-4, thi-l, E. coli Stock Center, CGSC, Yale University). There did not appear to be 
any differences between the 6925 and Lu53 strains that would influence the 
outcome of this study. However, later this plasmid was also introduced into the E. 
coli 6925 background to ensure that any differences observed were due to the 
plasmids and the resulting difference in ~-lactamase localization, not the 
background strain. 
2.2 Mouse Strains 
Inadvertently, two different strains of mice were used. Originally, the 
protocol was designed to use only one as the model organism, the 129xl/svJ strain 
from Jackson Laboratories. This mice strain is Nrampl +/+ [6]. This gene has been 
found to be essential in preventing the development of systemic infections in mice. 
It encodes an integral membrane protein that is recruited to the phagosome 
containing S. Typhimurium within macrophages [7]. This strain of mice will develop 
an acute infection but it will not become systemic because the pathogen is not able 




Due to a clerical error, a second strain of mice was also used, DBA/2J from 
Jackson Laboratories as well. Despite this error, fortunately the later strain had 
been used also for S. Typhimurium studies previously. While far more susceptible 
than 129xlfsvJ mice in terms of systemic infections, potentially due to a different 
genotype for the two Nrampl alleles, these mice develop infections that show 
intermediate symptoms between extremely susceptible mice strains, like BALB/c 
and resistant strains like 129xl/svJ [8], indicating that they do not typically succumb 
quickly to acute infections but succumb quickly to systemic infections when they 
develop. 
Mice were housed in cohorts of 3 to 4 and each cage was treated as one 
experimental unit. Fecal samples were collected daily from the bottom of the cage. 
Cage bottoms were then cleaned, sterilized, and returned to the cage. When 
innoculations were done or treatment was changed (ampicillin to no ampicillin in 
drinking water, or vice versa), mice were moved to clean and sterile cages with 
fresh food and water to avoid reexposure from the cage, food, or water. 
All mice were handled and cared for in the manner dictated by the 
Institutional Animal Care and Use Committee in accordance with IACUC protocol 
#10019. 
2.3 Innoculation with Bacterial Strains 
Before inoculation with a given bacterial strain, all mice were treated with 
500 Ilg/mL streptomycin, either in sterilized drinking water or by gavage of 100 ilL 
ofthe same concentration, to reduce native microbiota and thereby provide a 
suitable environment for colonization with the administered bacteria. Drinking 
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bottles were sterilized before being filled with streptomycin-containing drinking 
water. Fecal samples were collected daily and plated on Hektoen agar plates to 
asses gut microbiota. Streptomycin was administered fresh daily when 
administered in drinking water. 
Each bacterial strain was streaked from frozen stock onto Hektoen agar 
plates. For strains bearing the plasmid, over night growth was done on plates 
containing ampicillin at 100 Ilg/mL. The following day, strains were inoculated into 
and grown overnight in Lysogeny broth (LB). If the strain was supposed to carry a 
plasmid rendering it resistant to ampicillin, the LB was supplemented with 
ampicillin at 100 Ilg/mL to ensure the bacteria administered to the mice contained 
the plasmid. Samples (2 mL) from the overnight cultures were spun at 20,000 rpm 
for 10 minutes. The supernatant was removed and the pellets were resuspended in 
667 ilL phosphate buffered saline (PBS) (Invitrogen). From this solution, 100 ilL 
was administered to each mouse by gavage. 
Prior to gavage, food and water were removed from the mice for 4 hours to 
ensure no regurgitation during the procedure. A different sterilized gavage needle 
was used for each cohort. Mice were then monitored for several hours following the 
procedure to ensure that esophageal tearing had not occurred. For ampicillin 
resistant strains, mice were pretreated with ampicillin for at least a day prior to 
infection. The metabolic cost for the bacteria of carrying the plasmid made it 
difficult to colonize these strains without establishing an artificial selective 
advantage. 
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2.4 Preparation and Administration of Ampicillin 
Ampicillin was prepared in a concentrated stock, frozen, then thawed and 
diluted to the appropriate concentration for both agar plates and administration to 
the animals. Individual aliquots of the concentrated solution were only thawed once 
to reduce ampicillin degradation due to freezing and thawing repeatedly. 
All Hektoen plates with ampicillin contained the antibiotic at a concentration 
of 100 Ilg/mL. For administration to the mouse cohorts in drinking water, 
ampicillin from the concentrated stock was diluted into sterilized water and given to 
the mice in drinking bottles. In most cases, ampicillin was administered at 200 
Ilg/mL. In other cases, the dosage was increased to determine if higher dosage 
would result in complete clearing of infection. These bottles were cleaned and 
sterilized following streptomycin treatment. Ampicillin in drinking water was 
replenished every 24 hours. 
2.5 Sample Collection and Preparation 
Fecal samples were collected daily using tweezers to gather pellets from the 
bottom of specially designed cages with a mesh wire to catch pellets. The freshest 
samples were collected to ensure a sample most reflective of the current state in the 
mouse gut and because they were the easiest samples to process. 
Using an adapted protocol [9], fecal samples were weighed prior to 
processing. Samples were processed fresh or frozen and no difference existed in the 
data produced comparing frozen vs. fresh fecal samples(data not shown). Into each 
collection tube, 1000 ilL of sterilized dHzO was added. The pellets were broken up 
using a small plastic pestle with a blunt end and then vortexed vigorously to ensure 
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the pellets were as macerated as possible. These samples were then centrifuged for 
10 minutes at 800 rpm. The supernatant was removed and transferred to clean 
micro centrifuge tubes. The supernatant was then centrifuged for 5 minutes at 6000 
rpm. The supernatant from this centrifugation was then removed and the pellet 
containing bacteria was resuspended in 200 ilL sterile dHzO. This sample was either 
used to plate undiluted samples or to serially dilute samples so that it was possible 
to count colony forming units (CFUs). Dilutions were plated until CFUs on one plate 
were between 20 and 200 colonies to ensure accurate count. All samples were 
plated on Hektoen agar plates, with ampicillin (100 Ilg/mL) to determine ifthe 
strains growing were ampicillin resistant or without antibiotic. 
Plated samples were grown overnight at 37°C and CFUs counted following 24 
hours of growth. In some cases, samples were retained and if plated dilutions could 
not be counted accurately, further serial dilutions were performed and plated. 
3. Results 
3.1 S. Typhimurium grew with resistant strains of E. coli in presence of ampicillin. 
S. Typhimurium was able to colonize DBA/2J mice first cleared of gut flora by 
gavage with 100 ilL of 500 Ilg/ mL streptomycin and then inoculated with E. coli 
strains carrying plasmids rendering them resistant to the bactericidal activity of 
ampicillin. E. coli strains carrying pBR322 or pSLAR plasm ids were first inoculated 
into the mouse. Once the colonization of these strains was verified, ampicillin 
treatments at 200 Ilg/mL were begun, and the colonies obtained from fecal samples 
were able to persist indicating that the inoculum had contained plasmid-bearing 
bacteria. After ampicillin was removed, each cohort was then inoculated with S. 
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Typhimurium, which was allowed to colonize for several days. Summarily, 
ampicillin treatment was restarted to determine if S. Typhimurium was able to 
persist. After 4 days (96 hours) of growth treatment with ampicillin when S. 
Typhimurium was grown alone, the bacteria were not detectable from fecal samples 
(data not shown). 
When grown the E. coli Lu53 (pBR322), 24 hours after treatment with 
ampicillin, S. Typhimurium dropped to an almost undetectable level. However, after 
48 hours, the pathogen had begun to recolonize and grew steadily over the next few 
days (Figure 1a). Prior to treatment with ampicillin, S. Typhimurium grew at 
approximately 3.99x104 CFU per milligram fecal sample, although it did not displace 
Lu53 (pBR322) and they were growing in an essentially 50:50 ratio within the 
mouse gut based on fecal samples. 24 hours after the ampicillin regiment was 
begun, the S. Typhimurium detectable growth dropped to 409 CFU per milligram 
fecal sample, a reduction of 98.98%. At the peak of growth during ampicillin 
treatment, when grown with Lu53 (pBR322), S. Typhimurium was able to return to 
a level of 8.8x103 CFU per milligram fecal sample, 22% ofthe original growth 
without ampicillin present. This pattern was similar to results observed in a similar 
in vitro model (Perlin 2009), with an initial period of S. Typhimurium near 
disappearance followed by recolonization. 
When grown with E. coli 6925 (pSLAR) strain, different results for S. 
Typhimurium were observed. When initially grown with E. coli 6925 (pSLAR) 
without ampicillin, S. Typhimurium grew at the rate of 3.88x104, a comparable rate 
as that observed with Lu53 (pBR322). However, after 24 hours of treatment with 
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ampicillin, the observable number of CFUs for S. Typhimurium remained high, 
roughly the same for the first 24 hours and then dropping off to undetectable after 
48 hours. After 72 hours, S. Typhimurium began to show signs of recolonization, 
but only at very low levels, the maximum CFU count being 3.07x103 per milligram 
sample, 7.9% ofthe growth observed without ampicillin. 
3.2 S. Typhimurium was not cleared from gut during ampicillin treatment 
A replication of the previous study was again attempted in DBA/2J mice. In 
this case, streptomycin was administered at a concentration of 500 Ilg/mL in 
drinking water, rather than by gavage. Clearing of the gut was observed before 
bacterial inoculation occurred. Inoculation with bacterial strains was quickly 
followed by treatment with ampicillin for cohorts infected with resistant strains to 
assist in colonization of the gut. Once the E. coli infection was confirmed, S. 
Typhimurium 14028 was added to all four cohorts. 
When grown with E. coli 6925 not carrying a plasmid and therefore sensitive 
to ampicillin, S. Typhimurium completely displaced the well-established E. coli 
within 48 hours. Unexpectedly, when ampicillin treatment began at 200 Ilg/mL, 
while clearance had been observed previously when S. Typhimurium growing alone, 
the bacteria survived at a low rate throughout 11 days of treatment (Figure 2a), 
reaching a maximum of 754 CFU per milligram fecal sample. After an initial period 
of apparent clearing, S. Typhimurium was able to recolonize despite continued 
ampicillin treatment. 
When grown with E. coli 6925 (pBR322), S. Typhimurium was not able to 
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Figure 1: The return of S. Typhimurium following ampicillin treatment when grown 
with a) E. coli Lu53 (pBR322) and b) E. coli 6925 (pSLAR). 
S. Typhimurium was able to persist but at much lower levels than observed with E. 
coli 6925 (Figure 2b), reaching only a maximum of 66 CFU per milligram fecal 
sample. After 9 days of ampicillin treatment, no colonies of S. Typhimurium were 
detected in fecal samples from this cohort with continued antibiotic administration. 
When grown with E. coli 6925 (pSAR), again S. Typhimurium was not able to 
displace the originally established bacteria but instead grew with it. Upon initiation 
of ampicillin treatment, after a few days of what seemed to be elimination of the 
pathogen, S. Typhimurium returned and was observed at a level higher than 
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observed with the E. coli 6925 cohort, reaching a maxium of 1.5x103 CFU per 
milligram fecal sample (Figure 2c), although the concentration appeared to drop 
after 10 days of treatment. 
When grown with E. coli 6925 (pSLAR), S. Typhimurium grew along with the 
commensal species until the introduction of ampicillin. Upon initiation of the 
ampicillin regiment, the S. Typhimurium seemed to be eliminated. However,8 days 
into treatment, S. Typhimurium colonization was again observed at reasonably high 
levels, 727 CFU per milligram fecal sample (Figure 2d). This level of colonization 
was, however, comparable to levels S. Typhimurium was able to achieve when 
grown without a protective resistant E. coli strain. On day 11 of ampicillin 
treatment, all cohorts showed complete clearing of S. Typhimurium. Unlike the 
other three cohorts, this was the only day of total clearing observed for this cohort 
from fecal samples. 
After 11 days of treatment with ampicillin at 200 ~g/mL, the dosage was 
increased to 400 ~g/mL to determine if the S. Typhimurium could be cleared 
completely and for multiple days at a higher dosage. For the two days this level of 
ampicillin treatment continued, no S. Typhimurium CFUs were observed in the fecal 
samples from all four cohorts. After two days of treatment with ampicillin at 400 
~g/mL in drinking water, ampicillin treatment was removed from all four cohorts to 
determine if S. Typhimurium was able to recolonize. One day following the removal 
of ampicillin treatment, no CFUs appeared in any of the four cohorts. However, 48 
hours following the removal of ampicillin treatment all cages had returned to levels 
of S. Typhimurium colonization similar to those prior to initial treatment (Figure 3). 
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Thus, in only 48 hours without treatment, the few bacterial cells able to survive the 
increased level of antibiotic treatment, S. Typhimurium was able to reestablish 
colonization of the gut detectable in fecal samples as if treatment with ampicillin 
had never occurred. 
Attempts to use a similar infection model in 129xl/svJ mice failed, primarily 
due to the lack of establishment of the desired bacteria. The guts were cleared by 
the streptomycin but verifying the establishment of the inoculated strains was never 
determined from fecal samples. 
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Figure 2: Salmonella Typhimurium CFUs observed in cohorts treated with 
ampicillin (200 Ilg/mL) for a period of 11 days grown with a) E. coli 6925, b) E. coli 
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Figure 3: S. Typhimurium was detectable again in the fecal samples from all four 
cohorts following the removal of ampicillin. 
3.3 Sensitive E. coli strains are protected when grown with resistant strains 
Using DBA/2J mice, three cohorts originally inoculated with each of the three 
resistant strains of E. coli, E. coli (pBR322), E. coli (pSAR), and E. coli (pSLAR), while 
being treated with ampicillin to provide a selective pressure for the strains to retain 
their plasmids. After confirmation that the inoculated strains were established, 
ampicillin treatment was removed and E. coli 6925 was added. After giving the 
bacteria 24 hours to colonize the gut in absence of antibiotic treatment, ampicillin 
was returned to the cohorts in drinking water at 200 Ilg/mL. 
Because it was impossible on Hektoen plates to distinguish E. coli carrying 
the plasmid from plasmid-free cells, replicating plating was done to determine what 
portion of CFUs represented those with or without the plasmid. Cells from each 
sample were diluted and plated until individual cells could be counted. Individual 
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colonies were then streaked onto drug-free plates. The same colonies were then 
replica streaked on agar containing ampicillin to determine if any non-plasmid 
carrying colonies survived treatment with ampicillin. Since plasmid loss is possible 
given the metabolic cost of carrying it, it is not beyond the realm of possibility that 
some of the sensitive colonies are the result of cells losing plasm ids. However, if 
these bacteria were still able to survive in the presence of ampicillin, they would still 
be considered protected. 
After 8 days of treatment, ampicillin sensitive E. coli were able to survive in 
the presence of E. coli (pSAR) and E. coli (pSLAR). In the presence of E. coli 6925 
(pBR322), no sensitive E. coli were observed to have survive (data not shown). 
When grown with E. coli 6925 (pSAR), an average of 31. 7% of cells screened were 
sensitive over three days of treatment (Figure 4). In the cohort originally inoculated 
with E. coli (pSAR), all of the colonies screened were sensitive to ampicillin when 
















Days after Ampicillin Treatment 
Figure 4: Percentage of sensitive E. coli surviving treatment with ampicillin when 
grown with E. coli (pSAR). 
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Attempts to replicate this model in 129xljsvI mice also failed due to similar 
problems with establishing administered bacteria strains as discussed above. 
Streptomycin pretreatment followed by inoculation resulted in clear fecal samples. 
4. Discussion 
Previous in vitro models had demonstrated that ampicillin-resistant E. coli 
strains were able to provide protection for sensitive strains of both E. coli and S. 
Typhimurium when grown together in media as bacteria cultures. This protection 
was a function of the ability of the ~-lactamase produced by ampicillin-resistant 
strains to destroy enough ampicillin to allow these sensitive strains to grow without 
acquiring the ability to produce the enzyme themselves or other resistance 
mutations. 
When an in vivo model was attempted using mice, mixed results were 
observed. In the mouse, similar protective effects were observed for sensitive 
strains of E. coli, similar to results from in vitro studies [2], [3]. Because these 
sensitive strains were cleared easily when grown alone and treated with ampicillin, 
it is likely that this model did demonstrate the ability of resistant E. coli to protect 
their sensitive relatives. It was impossible to determine if the sensitive strains were 
actually the E. coli 6925 introduced or members of the originally resistant strain 
who had lost their plasm ids, so called cheaters [2], but it was clear that sensitive and 
resistant strains of E. coli were growing within the same mouse gut environment 
during ampicillin treatment. 
The proportion of sensitive to resistant E. coli growing together was 
consistent with what was expected given the location of the ~-lactamase within the 
19 
resistant cells. E. coli (pBR322) provided no detectable protection for sensitive E. 
coli, consistent with the ability to maintain p-Iactamase inside the resistant cell. E. 
coli 6925 (pSAR) provided almost complete protection for sensitive bacteria, with 
the majority of the bacteria persisting in the mouse after several days of treatment 
with ampicillin being sensitive. E. coli 6925 (pSLAR) produced intermediate results, 
as expected, since in this case, the p-Iactamase protein is tethered to the peri plasmic 
membrane and is acting upon ampicillin but not in the extracellular space. A 
substantial proportion of sensitive E. coli were able to survive despite treatment 
with a typically lethal dosage of ampicillin. 
However, S. Typhimurium presented the interesting case. At first it appeared 
that resistant E. coli were able to offer protection to ampicillin sensitive S. 
Typhimurium when grown inside the mouse simultaneously, similar to results 
previously observed [4]. However, it later became apparent that the dosage of 
ampicillin being administered was not sufficient to eliminate the S. Typhimurium 
infection alone. As such, it was impossible to determine if protection was actually 
occurring or if the S. Typhimurium infection was able to sustain because the dosage 
of ampicillin was not sufficient to eliminate the pathogen. It was apparent that the 
bacteria were not eliminated because upon the removal of ampicillin treatment, S. 
Typhimurium was able to recolonize the mouse gut. 
These inconsistent results prompted further investigation into the 
pharmokinetics of ampicillin, particularly the ampicillin as used in the manner 
prepared for these in vitro studies. Experiments were also designed to determine 
the effect of pH and temperature inside the mouse on the effectiveness of ampicillin 
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as an antibacterial agent. Moreover, it was pertinent to determine at what dosage of 
ampicillin S. Typhimurium was no longer able to survive inside the mouse gut when 
grown without ampicillin-resistant E. coli. 
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CHAPTER 3 
IN VITRO STUDIES OF THE PHARMAKINETICS OF AMPICILLIN AND IN VIVO 
ATTEMPTS TO CLEARS. TYPHIMURIUM INFECTION 
1. Introduction 
Ampicillin has been widely used to treat both Gram negative and Gram 
positive bacterial infections. However, even among the family of ~-lactams, it is not 
the most effective. While other ~-lactams like amoxicillin showed a measurable 
therapeutic effect at dosages as low as 20 mg/kg, ampicillin only had limited 
effectiveness at 200 mg/kg [10]. In humans, ampicillin has a low oral 
bioavailability, approximately 30 to 40% [11]. The serum half-life of ampicillin in 
humans is 1.8 hours [12], indicating that it is quickly degraded at physiological 
conditions. This may have contributed to results observed previously in in vivo 
models of S. Typhimurium and E. coli infections. 
For ampicillin like other antibiotic drugs to be effective, it must be able to 
penetrate the tissue in which the bacteria is found or survive the pH of the 
gastrointestinal tract to reach bacteria growing in the luminal space of the small 
intestines [12]. The low bioavailability of ampicillin is a product of its 
hydrophilicity and mechanisms of absorption when administered orally [11]. There 
is some evidence that ability to enter into infected tissues is decreased at decreasing 
pH, such as is found in the gastrointestinal tract [11]. If the ampicillin is able to 
survive the low pH conditions of the stomach, the pH within the intestine is near 
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neutral and entrance may be easier, although the effective dosage will be 
dramatically reduced. Even once the antibiotic survives physiological conditions to 
reach the site of infection, it still must be able to interact with the bacteria in a 
specific way to cause cell death. In the case of E. coli, ampicillin must traverse the 
outer membrane to reach its target, which is typically done through general 
diffusion porins within the bacterial cell [13]. 
In early murine models of S. Typhimurium infection, treatment of as. 
Typhimurium infection for three days with subcutaneous injections of ampicillin at 
a dosage of 64 mg/kg mouse weight prevented an increase of bacteria in the blood 
and spleen but did not eliminate the infection [12]. In the same study, significant 
decrease in bacterial load in the blood was found with dosages as low as 16 mg/kg 
while reduction of mortality was observed at dosages greater than 64 mg/kg [12]. 
These results indicate that ampicillin may be able to control the increase of as. 
typhimuium infection but not necessarily eliminate it completely. Moreover, these 
measures are of a systemic infection, not infection only within the gastrointestinal 
tract, and ampicillin treatment may be different within this system. 
Our previous attempts to model the ability of ampicillin resistant E. coli to 
provide protection for typically sensitive S. Typhimurium may have been 
complicated by the inability of ampicillin to effectively eliminate the pathogen 
infection. As such, the protection observed may be a result of ineffective dosage 
rather than the ~-lactamase produced by the resistant strains eliminating enough 
ampicillin within the system to allow some of the sensitive bacteria to survive. The 
following set of experiments was a means of examining both the pharmokinetics of 
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ampicillin as it was prepared for the murine model in Chapter 2 and attempting to 
find the dosage at which the S. Typhimurium infection could be eliminated. 
2. Materials and Methods 
2.1 Plasmids and Host Bacteria 
E. coli and S. Typhimurium strains were the same as used previously: E. coli 
6925, E. coli 6925 (pSAR), E. coli 6925 (pSLAR), and S. Typhimurium. Before each 
experiment, strains were streaked from pure frozen stock. LB broth was then 
inoculated with the bacterial strains and grown overnight. 
For in vitro work, overnight cultures were diluted by 100 and then grown 
until the cell densities measured spectophotometrically indicated logarithmic 
growth. 
2.2 Mouse Strains 
For in vivo models, both mouse strains previously described (Chapter 2) 
were used: DBA/2J and 129xlfsvJ. In vivo murine models were an attempt to 
determine the dosage of ampicillin to clear S. Typhimurium infection. Mice lived in 
cohorts of two. 
2.3 Innoculation with Bacterial Strains 
Before inoculation, mice were again treated with 500 Ilg/mL streptomycin in 
drinking water from sterilized bottles to render the gut clear for establishing S. 
Typhimurium infection. Food and water were removed for 4 hours prior to 
inoculation. Each mouse was administered by gavage 100 Ilg of bacterial 
suspension prepared as described previously. Mice were again monitored for 
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several hours following the procedure to determine if esophageal tearing had 
occurred during gavage. 
2.4 Preparation and Administration of Ampicillin 
Ampicillin was prepared as before, diluted from a concentrated stock for 
each administration to the mice cohorts. Five cohorts of mice were used, each 
receiving a different dosage of ampicillin, either in a single dosage or in drinking 
water: 200 ~g/mL as previously used, 400 ~g/mL, 600 ~g/mL, a single bolus of 100 
~L of 500 ~g/mL ampicillin, and a single bolus of 100 ~L of 500 ~g/mL followed by 
200 ~g/mL in drinking water. For administration in drinking water, fresh 
ampicillin was made daily. 
2.5 Minimum Inhibitory Concentration of Ampicillin 
Hektoen and LB agar plates were prepared containing decreasing 
concentrations of ampicillin: 800,400,200, 100,50, 12.5,6.25,3,12, and 1.56 
~g/mL. All five strains of bacteria, E. coli 6925, E. coli 6925 (pSAR), E. coli 6925 
(pSLAR), and S. Typhimurium, were grown to mid-logarithmic growth phase as 
confirmed by optical density. 15 ~L of bacterial suspension was spotted onto each 
plate and plates were grown for 24 hours, incubated at 3rc. Statistical analyses of 
growth/inhibition were done using I-tailed t-tests. 
2.6 Evaluation of Ampicillin Stability at different pH and Temperature 
Ampicillin was prepared at a concentration of 200 ~g/mL and then subjected 
to different conditions for 24 hours, with measurements taken ever 6 hours. These 
conditions were meant to simulate those found within the mouse and during the 
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administration of the drug as part ofthe experiment. As the ampicillin administered 
to mouse cohorts was left at room temperature, degradation of ampicillin at room 
temperature may have dramatically decreased. Ampicillin was left at room 
temperature, as well as stored at 37°C at the approximate at a pH of 4, the 
approximate pH of the murine and human stomach in a fasted condition; pH was 
maintained at pH 4 in acetate buffer. Sterilized dH20 at room temperature and the 
acetate buffering solution at 37°C were used as controls to determine if pH alone 
had an effect on bacterial viability. 
The pH of each solution was measured at 0 hours and again at 24 hours to 
determine if the pH of any of the solutions changed over time. Samples were taken 
every six hours and frozen until all samples had been collected. Discs made using a 
standard hole punch from filter paper were impregnated with 10 ilL of each solution 
and allowed to dry before being placed on bacterial plates. 
Sensitive strains of bacterial, E. coli 6925 and s. typhimuium, and resistant E. 
coli 6925 (pBR322) were grown in LB to mid-logarithmic phase as confirmed by 
measuring optical density. 150 ilL of each bacterial suspension were spread onto LB 
agar and Hektoen agar plates. Impregnated disks were placed on the plates and 
plates were incubated for 24 hours at 37°C. 
2.7 Measurement of bacterial sensitivity when grown in culture 
Three strains of bacteria, one known to be ampicillin sensitive, E. coli 6925, 
one known to be ampicillin resistant, E. coli 6925 (pBR322), and S. Typhimurium 
were grown in LB overnight from pure frozen stock. After growing overnight, all 
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three cultures were diluted by 100 fold into LB broth and grown to mid-logarithmic 
phase, as measured spectophotometrically. 
100 mL of LB broth containing ampicillin at 50, 100, and 200 Ilg/mL in 500 
mL flasks were inoculated with 100 ILL of the bacterial suspension. Samples were 
taken every 12 hours. Measurements of bacterial growth and/or survival were 
made spectophotometrically and by plating. 
2.8 Collection and Preparation of Fecal Samples 
Fecal samples were collected daily and processed as described in Chapter 2. 
3. Results 
3.1 Temperature and pH affect bactericidal properties of ampicillin 
For the control strain, resistant E. coli (pBR322), no difference was observed 
in the inhibitory properties of ampicillin regardless of time, temperature, or pH at 
which the ampicillin was stored for 24 hours; i.e., all measured zones of inhibition 
were O. The pH ofthe ampicillin solution was 7.0 at 0 and 24 hours and the pH of 
the buffered solution alone and containing ampicillin was 4.1 at 0 and 24 hours. 
For sensitive E. coli 6925, when grown on Hektoen plates, no inhibitory 
properties of sterilized water or the pH buffering system were observed. The zone 
of inhibition around the impregnated disc was significantly smaller after 6 hours of 
200 Ilg/mL ampicillin at room temperature than immediately after the ampicillin 
was prepared (p < 0.05), and continued to decrease over the course of 24 hours, 
indicating that the ampicillin was degrading at room temperature and therefore was 
less able to eliminate the sensitive bacteria. When plated on LB agar, a significant 
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difference was not observed from the initial zone of inhibition until the 24 hour 
sample (p < 0.005), but differences at 12 and 18 hours showed trends toward 
significance (p = 0.058 and p=0.018 respectively). 
For ampicillin 200 Ilg/mL stored at 37°C and pH 4 to simulate physiological 
conditions, the impregnated disks had significantly smaller zones of inhibition 
around them for E. coli 6925 grown on Hektoen after 24 hours (p<.05), and though 
not significant, a similar trend was observed after 18 hours (p = 0.18). When grown 
on LB plates, no significant decrease in zone of inhibition was observed over 24 
hours, potentially due to different agar properties. 
For S. Typhimurium 14028S, no differences in zone of inhibition were 
observed for 200 Ilg/mL at room temperature or stored at 37°C and pH when grown 
on Hektoen. However, when grown on LB plates, after 12 hours, the zone of 
inhibition around impregnated disks containing 200 Ilg/mL stored at room 
temperature was significantly smaller (p<.Ol) and continued to get smaller over the 
course of he 24 hour experiment. For the 200 Ilg/mL ampicillin stored at 37°C and 
pH, a significantly smaller zone of inhibition was observed after 6 hours (p<0.05) 
and over the 24 hour observation period, the observed zones of inhibition continued 
to decrease. 
The difference between the two sensitive strains may be a result of their 
different sensitivities to ampicillin. Moreover, S. Typhimurium was at a higher 
optical density (and therefore more cells were growing) at the time of plating than 
either E. coli strain. Either way, it is clear that the bactericidal properties of 
ampicillin decrease at room temperature and at physiological temperature and pH 
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over 24 hours. As such, the effective dosage the mice were receiving was not 
constant between changes of the ampicillin. 
3.2 Salmonella demonstrates a range of sensitivities to ampicillin 
When plated on Hektoen and LB plates containing various concentrations of 
ampicillin, S. Typhimurium was for the most part eliminated at fairly low 
concentrations but a few cells in each sample were able to persist across a range of 
concentrations (Table 1). 
Although most S. Typhimurium cells seem to be more sensitive to ampicillin 
than E. coli 6925, individual bacterial colonies were observed growing at 4 times the 
concentration that the original observed to be inhibitory, indicating ampicillin 
sensitivity was not homogenous within the population. While only a few cells were 
able to persist as these concentrations, few cells are needed to colonize a mouse gut. 
Hektoen LB 
E. coli 6925 12.5 12.5 
ii. coli 6925 (pBR322) > 400 > 400 
E. coli 6925 (pSAR) > 400 > 400 
~. coli 6925 (pSLAR) > 400 > 400 
S. Typhimurium 14028S 6.25 - 25 6.25 - 25 
Table 1: Minimum inhibitory concentrations of ampicillin for all five bacteria 
strains used expressed as Ilg/mL. A range is presented for S. Typhimurium. At 6.25 
Ilg/mL the majority of the drop of bacterial suspension showed no signs of growth 
but a few colonies could be seen growing within the ring. This was true up to 25 
Ilg/mL. 
3.3 S. Typhimurium is ampicillin sensitive at low levels whell.gfown in culture 
When given a single lethal dosage of ampicillin in culture, S. Typhimurium 
demonstrates the same sensitivity as a known ampicillin sensitive strain of E. coli. 
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Despite the detectable presence of both E. coli 6925 and S. Typhimurium upon 
inoculation, within 12 hours, the presence of ampicillin had rendered both 
undetectable by either spectophometric measures or plating (Figure Sa and Sb). 
Conversely, E. coli 6925 (pBR322) detectable at a comparable level at inoculation 
grew to mid-logarithmic phase within 12 hours (Figure Sc). 
When grown in culture, S. Typhimurium does not demonstrate the ability to 
survive in the presence of lethal dosages of ampicillin and demonstrates sensitivity 
similar to that of a non-plasmid bearing strain of E. coli 6925. Unlike observations in 
the host system, a single dosage was sufficient to eliminate a population of S. 
Typhimurium while prolonged dosing with ampicillin could not eliminate the 
bacteria from the mouse. 
3.4 Attempts to clear S. Typhimurium from mouse gut were unsuccessful 
The S. Typhimurium model was attempted in DBA/2J mice. However, many 
of the mice died from infection within a few days despite treatment with ampicillin. 
More notably, the last surviving mouse from this group was one from the cohort 
receiving the lowest level of treatment. The most important information gathered 
from this group was the inability to predict the course of infection in this strain of 
mouse known to be more susceptible to S. Typhimurium than the 129xljsvJ strain of 
mice. There is the possibility that some mice were injured during gavage. However, 
there is greater possibility that these mice developed systemic infections that 
ampicillin was not capable of effectively treating. Because these animals quickly 
succumb to systemic infections, they are not a good organism in which to model the 
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Figure 5: CFUs of a) E. coli 6925, b) S. Typhimurium, and c) E. coli 6925 (pBR322) 
over the course of 36 hours following inoculation into LB broth containing lethal 
dosages of ampicillin. For c), the CFUs at 0 hours following inoculation was 
approximately 3x104 , similar to the other two strains. 
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In the more resistant mice, the model was more successful. Five cohorts of 
two 129xljsvJ mice each were inoculated with S. Typhimurium 14028S and then 
administered different dosages of ampicillin by bolus or drinking water: 200 
Ilg/mL, 400 Ilg/mL, 600 Ilg/mL, a single bolus of 100 ilL of 500 Ilg/mL ampicillin, 
and a single bolus of 500 Ilg/mL ampicillin followed by 200 Ilg/mL ampicillin in 
drinking water. Ampicillin was administered for 12 days. 
Cohort 4 received a single bolus of 100 ilL of 500 Ilg/mL ampicillin by gavage. 
Prior to treatment, the detected bacterial load was 18.2 CFUs per milligram fecal 
sample. 24 hours after dosage, the bacterial load increased and continue to remain 
high, reaching a maximum of 2.38x10s during measuring (Figure 6). It appears that 
whether by the nature of the infection or the nature of detection, the bacterial load 
measured in fecal samples does not remain constant but can fluctuate quite 
dramatically. While it began fairly low, it had increased by a factor of 1000 within a 
few days and dropped back down to toward the end of measurement. This may be a 
product of the animal becoming sicker as the bacterial load increased, eating and 
drinking less, and therefore defecating less so that the fecal sample is not 
representative of the current state of the colon environment. 
Cohort 1 received a constant dosage of 200 Ilg/mL ampicillin in drinking 
water. When treatment began, the measured bacterial load was 2.6Sx104 CFUs per 
milligram fecal sample. After 24 hours of ampicillin treatment, S. Typhimurium CFUs 
remained high, 2.76x103 CFUs per milligram fecal sample. After 48 hours, bacterial 
load had decreased and remained low through the remainder of treatment. Samples 
would be clear of S. Typhimurium for a few days and then would return a very low 
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Figure 6: CFUs of S. Typhimurium from samples in Cohort 4 following bolus 
administration. 
levels without the readministration ofthe bacteria (Figure 7a). After 12 days of 
ampicillin treatment, treatment was removed. Within 24 hours detectable bacterial 
load returned to the same level observed before treatment, 3.28x103 CFUs per 
milligram fecal sample (Figure 7b). 
Cohort 2 received a dosage of 400 ~g/mL ampicillin in drinking water. When 
treatment began, the measured bacterial load was 8.87x102 CFUs per milligram 
fecal sample. After 24 hours of ampicillin treatment, the bacterial load remained 
high. After 48 hours of treatment, CFUs in fecal samples decreased dramatically, 
remaining undetectable for the last 5 days of treatment (Figure 8a). However when 
ampicillin treatment was removed, within 24 hours, the detectable CFU level in fecal 
samples became even higher than it had been prior to treatment, 9.07x103 (Figure 
8b). Unlike Cohort 1, this high level of bacterial infection was not sustained, 
although S. Typhimurium remained detectable for 4 days after removal of ampicillin. 
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Cohort 3 received a dosage of 600 Ilg/mL ampicillin in drinking water. When 
treatment began, the measurable bacterial load was 38.4 CFUs per milligram fecal 
sample, much lower than the established bacterial load in the first two cohorts. 
After 24 hours of treatment, as with the previous two cohorts, the bacterial load 
remained close to the pretreatment level. After 48 hours of treatment with 
ampicillin, the bacterial load dropped to undetectable; however, there were two 
spikes when CFUs of S. Typhimurium were identifiable within the 12 days of 
ampicillin treatment (Figure 9a). After the removal of ampicillin, the bacterial load 
returned, at an even higher level than prior to treatment, 2.53xl03 CFUs per 
milligram fecal sample (Figure 9b). Unlike the first two cohorts, bacterial level 
return did not happen within the first 24 hours but instead took 3 days. 
Cohort 5 received the single bolus of 100 ilL of 500 Ilg/mL ampicillin 
followed by 200 Ilg/mL ampicillin administered in drinking water. Prior to 
treatment, the bacterial load was detected at 2.61Exl03 CFUs per milligram fecal 
sample. 24 hours after the administration of the bolus, the bacterial level had 
decreased but returned to pretreatment levels 72 hours following the bolus 
administration despite administration of ampicillin (Figure lOa). Unlike Cohort 1, 
which also received 200 Ilg/mL ampicillin in drinking water, the detectable level of 
S. Typhimurium remained higher in Cohort 5 throughout the course of ampicillin 
treatment. Potentially, the original bolus of ampicillin had killed the extremely 
sensitive S. Typhimurium cells, leaving the more resistant ones to persist. After the 
removal of ampicillin, bacterial load increased to a level much higher than 
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Figure 7: CFUs of S. Typhimurium from samples in Cohort 1 a) during ampicillin 
treatment (The inset graph is an enlargement of days 2 through 12 where it is 
apparent that the detectable level of S. Typhimurium did not stay at zero.) and b) 
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treatment (The inset graph is an enlargement of days 2 through 12. Bacterial load 
dropped dramatically and then decreased gradually to 0 for the last five days of 
treatment.) and b) following removal of ampicillin. 
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Figure 9: CFUs of S. Typhimurium from samples in Cohort 3 a) during ampicillin 
treatment (The inset graph is an enlargement of days 2 through 12. Bacterial load 
dropped decreased to undetectable with a few spikes of detectability during 
treatment.) and b) following removal of ampicillin. 
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Figure 10: CFUs of S. Typhimurium from samples in Cohort 5 a) during ampicillin 
treatment and b) following removal of ampicillin treatment. 
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4. Dis.~ussion 
Despite the sensitivity that S. Typhimurium demonstrated in vitro, based on 
the return of the infection to detectable levels once the ampicillin treatment was 
removed, the infection was not completely cleared in the murine model. While 
there was no additional inoculation provided to the mice, it is not impossible that 
they were contaminated in other ways. While mice with infections were separated 
from those receiving treatment and their fecal samples processed separately, a 
possibility is that animal technicans coming into the mouse room unknowingly 
cross-contaminated cohorts. However, it may be more likely that the bioavailability 
of ampicillin is so low that even at higher doses, it was not an effectively lethal 
dosage to S. Typhimurium at physiological conditions. 
It is also unclear whether a measurement of bacterial load through fecal samples is 
an accurate impression of the internal state of the mouse infection. Even in 
resistant strains of mice, S. Typhimurium may be able to grow within the epithelial 
cells of the intestine [15]. While they may not be able to establish a systemic 
infection from this point, due to the genotype of the host as related to Nrampl + vs. 
Nrampl- and the resistance of their macrophages to harboring S. Typhimurium and 
carrying them to other organs, the bacteria may impervious to ampicillin treatment. 
Ampicillin has difficulty surviving the pH of the stomach and similar difficulty 
crossing into host tissue, where it must travel to reach its target. 
Moreover, if S. Typhimurium are moving inside epithelial cells, the bacteria 
may not be detectable in fecal shedding, which was the measure of data collection 
for this study. Removing the ampicillin may create a different environment that 
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either allows for more pathogenic bacteria to grow actively or allows the 
recolonization of the gut within the luminal space by bacteria that have been hiding 
from antibiotic treatment. 
Because E. coli 6925 is very sensitive to ampicillin in vitro and is easily 
cleared in the murine model, it is likely that the protective effect observed of 
resistant E. coli for sensitive E. coli in the presence of ampicillin was supportive of 
previous observations made in vitro, not the product of a nonlethal dose being 
administered. E. coli 6925 (pBR322) provided no detectable protection for sensitive 
E. coli while E. coli 6925 (pSAR) provided almost complete protection for sensitive E. 
coli. E. coli 6925 (pSLAR) protected sensitive E. coli at an intermediate rate. 
In vivo, by the methods used in these studies, it was not possible to 
demonstrate the complete clearance of S. Typhimurium infection, even with high 
dosages of ampicillin treatment. As such, it is uncertain that the protective effects 
observed were actually protection but are more likely the product of a nonlethal 
dose of ampicillin being administered. 
Within the S. Typhimurium population, each bacterial cell may be more or 
less susceptible to the mechanism by which ampicillin works. This was particularly 
obvious in Cohort 5, which received a large single dosage of ampicillin followed by a 
continuously available dose at a lower concentration of ampicillin. During the 
continued ampicillin treatment, S. Typhimurium was able to persist at higher levels 
than in the other three cohorts receiving continuous ampicillin treatment, 
potentially this was due to the high one time dose, where a larger proportion of cells 
within the S. Typhimurium population had lower levels of susceptibility. 
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While the infection was never cleared, it was demonstrated that increasing 
the ampicillin dosage was more effective at reducing the S. Typhimurium numbers. 
In the case of Cohort 3 receiving the highest dosage of ampicillin within this study, S. 
Typhimurium was not able to recolonize as quickly, either due to the longer time 
needed for the mouse to metabolize ampicillin out of its system but more likely 
fewer living cells were left to recolonize. 
In vitro work with ampicillin also demonstrated that over time at room 
temperature and at physiological temperature and pH the bactericidal properties of 
ampicillin were reduced, indicating a degradation of the ~-lactam antibiotic over 
time under these conditions. Potentially in murine experiments, the dosage of 
ampicillin did not remain at a constant level, and at lower effective ampicillin levels, 
the S. Typhimurium cells were able to persist in the gut. 
Because ampicillin was administered in drinking water, it was not possible to 
control the intake of each individual mouse. Even if most S. Typhimurium cells can 
be eliminated at low ampicillin doses in vitro, no measures were taken to determine 
the serum level of ampicillin in the mice during treatment. Because there was a 
delay of 48 hours in all cases before a dramatic decrease in bacterial load was 
observed, it is likely that the mice have to build a certain level of ampicillin before 
treatment becomes effective. However, the level of dosage appears to have been too 
low to allow the mice to build a sufficient level to eliminate S. Typhimurium 
infection. If an effective dosage of ampicillin is 60 mg/kg for mice (Anton 1982), 
each mouse would have to consume 16.4 mL of water per day of 200 ~g/mL, which 
is much higher than the mice consumed. Moreover, mice do not constantly drink. 
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Potentially during periods of sleep or inactivity, the decrease in their levels of 
ampicillin was sufficient to allow S. Typhimurium to persist. Patterns of eating and 
the movement of food through the gastrointestinal tract may change the 
bioavailability and therefore bactericidal properties of ampicillin. While 
subcutaneous administrations of ampicillin have been the norm in previous studies, 
oral administration may more quickly reach the site of infection but cannot be 
controlled if administered in drinking water and may not produce an effective 
dosage. 
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CONCLUSIONS FROM IN VIVO MODELING 
The purpose of the current research was to develop a protocol to model in 
mice phenomena that had been observed in an in vitro setting. The nature of the 
interaction between S. Typhimurium and its host proved to heavily influence the 
ability to model within the mouse. S. Typhimurium behaves predictably in vitro. 
The bacteria demonstrates sensitivity to ampicillin at low levels. However, within a 
live host, the bacteria demonstrate an ability to evade both the attempts of the 
immune system to eliminate it and the antibiotics delivered to the host. Much of this 
survival may be mediated by the evolutionary history between host and pathogen. 
The protocol that was used to administer the bacteria to the mice may also 
have provided a better model for human gastroenteritis but it may have 
inadvertently created a selective advantage for S. Typhimurium. Resistant strains of 
mice like 129xlfsvj typically do not develop inflammation within the intestinal tract 
in response to S. Typhimurium infection as is seen in humans [14]. Pretreatment 
with streptomycin, as used in the current protocol, induces inflammation in the 
intestinal tract that mimics that seen in humans [14]. However, this inflammation 
allows S. Typhimurium to have selective advantage over the other bacteria that may 
be growing in the gut, induding any more that may be introduced purposefully. For 
example, in the inflamed gut, S. Typhimurium is able to use alternate carbon sources 
that other microbiota are not able to utilize [15]. 
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Moreover, there is evidence that S. Typhimurium can grow within epithelial 
cells of the small intestine, even in resistant strains of mice that do not develop 
systemic infections [16]. This subpopulation of the infecting bacteria are found 
within epithelial cells, in a state of hyperreplication, ready to re-enter the intestinal 
tract from inside the epithelial cells [16]. Even in the instance of antibiotic 
treatment, these bacterial subpopulations may be able to survive inside the 
epithelial cells given the low bioavailability of ampicillin and its difficulty getting 
inside host cells as well as bacterial cells. Upon removal of the ampicillin, these 
bacteria may leave the epithelial cells, return to the intestinal lumen, and may be 
able to recolonize the host. Despite the fact that based on fecal samples, the 
infection had apparently cleared, upon removal of the antibiotics these bacteria 
were able to recolonize the gut, which is why the return of infection was observed. 
Clearly, some of these bacteria will be released from epithelial cells while treatment 
with antibiotics is occurring. However, because so few are needed to colonize the 
gut, if only a handful survive inside epithelial cells during antibiotic treatment, the 
return of infection will be observed. The same return to recolonize is not observed 
in an in vitro setting because there are no epithelial cells in which to evade 
ampicillin activity. S. Typhimurium as a pathogenic bacterium, has evolved inside of 
and along with its host and as such developed means to persist. The fact that it is 
able to survive inside epithelial cells even in those mice that do not develop 
systemic infections speaks to the bacteria's ability to evade the immune system as 
well as maintain infection by constantly inserting new pathogens into the intestinal 
tract. 
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In order to develop a murine model for the protection of ampicillin-sensitive 
S. Typhimurium by ampicillin-resistant strains of E. coli, the adaptive measures that 
S. Typhimurium takes to avoid the host immune system must also be considered in 
attempting to treat the infection with oral antibiotics. Dosage of ampicillin is one 
consideration to the approach taken. Because the bioavailability of ampicillin is low, 
even at dosages that eliminate the bacteria in the lab, S. Typhimurium is able to 
survive inside the mouse, potentially because the effective dosage that the mouse is 
receiving is significantly less than the concentration in the drinking water. 
However, this would have to be carefully watched, because at some point high 
dosages of ampicillin may be toxic to the mouse or, be too high for protection to be 
afforded by the resistant E. coli. 
Instead of streptomycin, another antibiotic may need to be used initially to 
clear the gut of innate microbiota. Because streptomycin induces inflammation that 
allows S. Typhimurium a selective advantage not normally found in the murine 
model of S. Typhimurium infection, a different antibiotic may provide a more even 
playing field for the two strains of bacteria introduced. Unfortunately, eliminating 
the inflammation also eliminates the similarity with the human gastroenteritis but it 
may allow more dissection of the interaction between a resistant strain of E. coli and 
S. Typhimurium during treatment with ampicillin. 
Ultimately, because many of the properties of S. Typhimurium are only 
observed within a live host, they cannot be replicated in vitro. As such, it may never 
be possible to develop a protocol for this model inside a host because S. 
Typhimurium is able to persist with and without the presence of the resistant strain. 
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CHAPTER 4 
THE BEST OF TIMES AND THE WORST OF TIMES 
How Salmonella uses Alternate Sigma Factors to Survive 
1. Introduction 
Salmonella enterica are rod-shaped, facultative anaerobic, Gram-negative 
members of the Enterobacteriacae family [17] . Most people have heard of the 
bacteria and generally associate it with food-borne illness. Despite general public 
knowledge of the health risks associated and precautions taken to prevent spread, 
Salmonella continues to cause many problems internationally. One approach 
toward curbing this spread and reducing the negative impact of S. enterica could be 
genetic analysis, with an ultimate goal of understanding why the bacteria are able to 
survive host immune responses capable of eliminating most bacteria. 
It has been suggested that the Salmonella genus diverged from Escherichia 
coli somewhere between 100 and 150 million years ago [17]. While there is 
evoluntionary distance between the two genera, much of the genetic information 
has been conserved, and as a result, the study of one organism has provided insight 
into the study of the other. Salmonella spp. are generally considered to be 
pathogenic and can have both warm- and cold-blooded hosts [17]. More recent 
evolution has occurred within the Salmonella genus itself. Salmonella enterica has 
evolved into many different subspecies and serovars who manifest is dramatically 
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different ways across a variety of hosts despite sharing 95% of the same genetic 
information [18]. From a medical and sanitation viewpoint, the genetics of 
Salmonella are particularly important to study. Although a single-celled organism, 
due to its long evolutionary history with humans and other host organisms, these 
bacteria have developed several sophisticated mechanisms to survive immune 
systems of its hosts, and evade sanitation efforts to kill it. Understanding this 
survival at the most fundamental of levels may help to more specifically combat the 
bacteria. 
Salmonella typically reach their hosts through the consumption of 
contaminated food or water. Once inside its host, the bacteria must persist through 
various levels of pH, temperature, osmolarity, and nutrient availability [19]. The 
pathogen must also face various attempts by the host's immune system to eliminate 
it. The organism must address each different environment and assault on the 
bacteria's integrity in order to survive. The ability of the organism to thrive in a 
multitude of different environments and establish infection is mediated by the 
regulated expression of different genes. 
Because Salmonella is an important pathogen and can cause debilitating 
disease and even death, research typically focuses is on the properties of the 
organism that give it the ability to infect hosts. When studying virulence with 
respect to genetics, there are a multitude of approaches. Once a gene of interest has 
been discovered, the gene or gene product can be rendered nonfunctional and the 
resulting phenotype examined. Conversely, given a particular phenotype, 
researchers can examine genes present among strains sharing that characteristic. 
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While there are a multitude of regulatory pathways within Salmonella that 
can influence gene expression, one of the most fundamental comes from the usage of 
alternate sigma factors by the cell's RNA polymerase. Sigma factors facilitate 
differential gene expression by reversibly binding to the RNA polymerase core 
enzyme and providing specificity for certain promoter regions. The various sigma 
factors have different affinities for particular promoters as well as for the core 
enzyme itself. Similar to other cellular proteins, sigma factors are regulated at a 
variety of levels. Transcription in Salmonella, as in all prokaryotes, requires a sigma 
factor, and ultimately all gene expression is affected by sigma factors activity. 
Sigma factors were originally discovered as protein factors that stimulate 
RNA synthesis from DNA using DNA-dependent RNA polymerase [20]. It was later 
discovered that there were multiple sigma factors and that these alternate sigma 
factors allowed for differential gene expression through different affinity for the 
RNA polymerase core enzyme and for recognition of different promoter consensus 
sequences. It appears that the majority of sigma factors are evolutionarily related. 
These proteins all share four regions of similarity indicative of a common function 
[21]. For the group of closely related sigma factors, special regions within the 
protein recognize specific areas of the DNA as promoters versus non-promoter 
regions [22]. These DNA regions include conserved sequences centered around the -
35 and -10 positions with respect to the transcription initiation site. By truncating 
the sigma protein at various locations, researchers have been able to determined 
that four conserved regions of the sigma factors were responsible for locating 
different areas of the promoter region. For example, region 4 of the sigma factor is 
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found to recognize the consensus sequence around -35, while regions 2 and 3 
recognize the -10 consensus sequence [22]. Region 1 of the sigma factor, the amino 
terminus of the protein, blocks regions 2, 3, and 4 from interacting with the DNA 
[23]. Binding of the sigma factor to the core enzyme blocks region 1 and allows 
interaction of the other three regions with the DNA [6]. In this way, the sigma factor 
cannot interact with DNA without being bound by RNA polymerase. While it was 
understood that a sigma factor was necessary to facilitate transcription, their power 
to regulate gene expression was not fully understood. 
2. Early Virulence-Related Genetic Studies 
As with most pathogenic microorganisms, early genetic research focused on 
the disease-causing properties of Salmonella. Preliminary studies involving 
virulence properties of Samonella revealed that in the absence of a functional copy 
of several genes, the bacteria was unable to survive to cause infection inside its host. 
Further studies of each of these genes revealed that while all of the genes were 
required for optimal virulence, the gene expression was not under the same 
regulatory control. Baumler and his colleagues examined nearly 30 mutant strains 
of Salmonella Typhimurium that had shown attenuated ability to infect and survive 
inside mouse macro phages [24]. These strains had been created by the insertion of 
transposons in various locations of the genome and examining phenotype. By 
sequencing the areas around the transposable elements, researchers were able to 
identify that six of the regions disrupted by transposons corresponded to known 
genes. Baumler concluded that these genes all made contributions to the virulence 
properties of Salmonella. 
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Some of the particular genes that Baumler concluded were disrupted in the 
attenuated strains were purD, prc,j1iD, and nagA [24]. Other researchers have 
examined the transcriptional control of these genes to understand why they are so 
essential to the virulence capabilities of Salmonella. The dependence of these genes 
on different sigma factors for expression shed more light into not only the ability of 
Salmonella to survive in a variety of harsh conditions but also the virulence 
mechanism of the bacteria. 
As many sigma factors are closely related, there is a high degree of homology 
between their structures and therefore promoter affinities. However, as few as one 
or two base pair change can dramatically change which sigma factor recognizes the 
promoter [25]. The purD gene encodes 5' -phosphoribosylglycinamide synthetase, 
which is involved in purine nucleotide synthesis [26]. While these genes have easily 
identifiable -10 consensus sequences, none appear to have the -35 region similar to 
those typically recognized by primary sigma factor, (J70 [27]. Further research 
revealed this gene and others related to purine synthesis were all proceeded by 
what researchers have called a Pur Box that seems to be required for their 
transcription, as well as an area for regulation by purine levels in the cell [28]. These 
PurBoxes are bound by repressor proteins that must be removed in order for 
transcription of the pur genes to happen [28]. It stands to reason that purines 
would need to be synthesized regardless of environmental condition. If 
environmental conditions dictate the most dominant sigma factor and purines are 
an essential part of cellular function in all conditions, multiple sigma factors should 
be able to direct the transcription of their corresponding genes. Potentially, the 
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ambiguity of the promoter region for these genes demonstrates the ability to be 
used by multiple sigma factors and PurBoxes allow for regulation in a concentration 
dependent manner. 
A second gene, prc, encodes for a protease that in closely related organisms 
has been found to playa role in response to cell wall stress [29]. In these organisms, 
prc is preceded by a consensus sequence for a sigma factor showing a great deal of 
similarity to the sigma factor in E. coli and Salmonella that responds to a variety of 
global stresses, including damage to the cellular envelop [29]. 
The fliD gene encodes for part of the flagellar filament, needed for the 
motility of the bacteria [21], [30]. This gene is proceeded by a consensus sequence 
that can only be used by the flagella-specific sigma factor [21] and is part of a highly 
temporally and spatially regulated pathway that ensures flagella are expressed 
readily in times that motility is necessary and repressed when the bacteria has not 
formed the appropriate primary structures for the flagellar. 
The nagA gene product is N-acetylglucosamine-6- phosphate deacetylase in 
E. coli and has the same function in Salmonella Typhimurium [22]. These gene was 
found to have consensus sequence in the -10 region requiring the activating a 
magnesium sensitive regulator in the presence ofthe housekeeping sigma (}"70 [31]. 
Based only on the extracellular availability of magnesium, the primary sigma factor 
is responsible for the transcri ption of the gene provided a secondary regulatory 
system is activated. 
With the genes that Baumler examined, in combination with other research 
indicating that each of these types of genes was under different regulatory control 
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by particular sigma factors, a pattern began to emerge. Genes responsible for the 
organism's response to particular threats to its integrity were under the 
transcriptional direction by particular sigma factors. The importance of sigma 
factors as transcriptional regulators is further revealed by their stability over time 
[32] and the high degree of homology among sigma factors responding to a 
particular stimuli between closely related species [33]. The use of alternate sigma 
factors by Salmonella like all prokaryotes allows for a coordinated expression of 
genes and an easily controlled process to promote survival even in the most harsh of 
conditions. 
3. A Tale of Six Sigmas ... 
Individually, each type of sigma factor was purified, isolated, and determined 
to facilitate RNA transcription in the presence of RNA polymerase core enzyme and 
other appropriate molecules. To date, six different sigma factors have been 
discovered within the Salmonella genome that are responsible for transcription 
from a variety of promoters in response to different phases of the bacteria's lifestyle 
as well environmental conditions. Acting together in a complex, as an 
interconnected web of gene regulation, they enable Salmonella to withstand and 
thrive inside infected hosts. 
Sigma factors were characterized as proteins before their functions as 
essential elements of the holoenzyme became clear. As such, each sigma factor is 
known by a variety of names. Designations with rpo or Rpo are used across species 
and refer to the particular stress to which a particular sigma factor responds. A 
more contemporary convention is to use a lower case Greek sigma with the 
52 
molecular weight of the sigma factor as s superscript. In this text, all molecular 
weights refer to those found in Salmonella and E. coli. 
Most sigma factors, a70 , a E, a H, as, and a F, belong to the same family of sigma 
factors, potentially all derived from some ancestral form or ancestral regulatory 
process. The other sigma factor, aN, belongs to a different family, although it is the 
only modern day example found, and may belong to a more ancient regulatory 
system that has become obsolete with current lifestyles of bacteria like Salmonella. 
While the housekeeping or primary sigma was found to facilitate most gene 
expression during exponential growth, each of the other sigma factors was found to 
help the organism address a number of different environmental stresses. Each 
sigma factor has a consensus sequence in the promoter region for which it has the 
greatest affinity. The relative affinities of mUltiple sigma factors for the same 
promoter region may determine which sigma factor recognizes it at a specific 
concentration of sigma factors within the cell. Much research related to sigma 
factors has focused on determining sigma regulons, the specific suite of genes under 
their transcriptional control. 
3.1 aN - Nitrogen Regulation 
aN, a 54, or RpoN seems to be more evolutionarily distant from the other 
alternate sigma factors than they are from each other, and it may be the remnants of 
a more ancient regulatory system that has since become less important to survival 
of Salmonella. In fact, some researchers believe that the processes governed by aN 
may not be essential or may be under transcriptional control of another sigma factor 
[34]. These processes include nitrogen fixation, dicarboxylic acid transport, and 
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hydrogen oxidation [34]. Downregulating expression from RpoN-dependent genes 
provides increases resistance to killing by host cationic antimicrobial peptides [35], 
indicating that some of these processes may even be detrimental to the organism in 
certain conditions. In some related species aN is related to pathogenicity, but that 
does not appear to be in Salmonella [36]. 
The differences between aN and the rest of the sigma factors are profound. 
There is almost no sequence similarity between the rpoN gene and genes for other 
known sigma factors, also suggesting a different origin [34]. aN promoters are 
unique in that they have conserved consensus sequences centered at -24 and -12 
nucleotides from the transcription start site, as opposed to -35 and -10 conserved 
regions found in promoters recognized by other sigma factors [37]. A highly 
conserved RpoN-Box is involved in the recognition of the -24 and -12 DNA elements 
[37]. The distance between the -24 and -12 elements is more stringent than the 
analogous distance between the -35 and -10 elements for the a70 family of sigma 
factors, indicating a highly controlled regulation [37]. Moreover, the sequences at 
the -24 and -12 elements have highly conserved GG and GC regions respectively, 
also suggesting a high level of regulatory control [37]. 
While the aN protein is very different from other alternate sigma factors, the 
interaction between the sigma factor and template DNA is also distinct. The a70 
family of sigma factors do not form stable closed complexes as part of the 
holoenzyme and transcription will start spontaneously [37]. Unlike other sigma 
factors, the aN and core enzyme form a stable closed complex. In this way, aN 
binding to the core enzyme actually blocks transcription because the open complex 
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must be activated [38]. The binding of the RNA polymerase holoenzyme with aN as 
the sigma factor cannot induce DNA melting alone, similar to the RNA polymerase II 
system in eukaryotes [39], which is essential for the start of transcription. In fact, it 
has been hypothesized that aN may bind to DNA first rather than binding to the core 
enzyme first [39]. This is supported by the fact that aN binds to a different location 
on the core enzyme than a70 and in doing so may be able to assist in DNA melting 
once activated [39]. 
Because it forms a stable closed complex, the RNA polymerase with aN as the 
sigma factor requires enhancer proteins for activation. Each enhancer protein is 
under the regulation of its own signal transduction pathway, allowing response to 
various environmental conditions [38]. All the enhancer proteins have in common 
hidden ATPase activity that allows for the DNA melting necessary to initiate 
transcription [38]. 
3.2 The Housekeeping Sigma a70 
The other five sigma factors appear to be evolutionary related, developing 
from the original or primary sigma factor. RpoD or a70 is the housekeeping sigma 
factor and is responsible for the transcription of most of the genes in bacterial cells 
growing exponentially [40]. When rpoD was found in the genome for E. coli, it was 
determined that the gene sequence had a high degree of homology between other 
rpoD genes from closely related species [41]. Further genomic analysis determined 
that rpoD is found in an transcript with the 30S ribosomal protein S21 and DNA 
primase [42]. This operon was the first discovered operon containing proteins 
involved in transcription, translation, and replication [42]. Ea70 (the holoenzyme 
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containing the core enzyme associated with cr70) does not form a stable closed 
complex and transcription begins spontaneously [37]. Moreover, the cr70 
concentration found inside a cell undergoing exponential growth is less than 
concentration of core enzymes, indicating the level of the sigma factor present may 
regulate the level of transcription [42]. 
3.3 crE - Response to Extracytoplasmic Stress 
When the bacteria faces stressors, other sigma factors are involved in the 
expression of genes necessary to survive the stress, such as crE , cr24, or RpoE, which 
results in transcription of genes to combat envelop stress [43]. RpoE is 
constitutively expressed in the bacteria, held inactive by interaction with various 
binding proteins. The rpoE gene seems to be the most highly conserved of alternate 
sigma factors across several species, as are the genes under its transcriptional 
control, suggesting an high level of importance of these functions to the survival of 
the mUltiple bacterial species. 
RpoE must be able to respond to a signal coming from outside of the cell, 
while the protein itself exists within the bacterium. It appears a transmembrane 
protein, RseA, interacts with RseB on the periplasmic side and with crE on the 
cytoplasmic side. An area of the DegS protein on the periplasmic side recognizes 
unfolded proteins resulting in proteolysis of the periplasmic side of RseA. Cleaved 
RseA is a target for RseP, which then cleaves the transmembrane portion of RseA, 
releasing the RseA/ crE complex from the membrane and the unstable cytoplasmic 
portion of RseA is quickly degraded by cytoplasmic proteases [44]. RseB also 
interacts on the peri plasmic side with both DegS and RseP to control the activity of 
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these proteases in the absence of a stress response [44]. Upon perception ofthe 
extracytoplasmic stress in the form of misfolded proteins, (JE is then able to interact 
with the core enzyme of RNA polymerase. The strength of the signal is directly 
proportional to the number of misfolded outer membrane proteins, which is a 
reflection of the extracytoplasmic stress. 
While response to envelop stress is typically the signal necessary to release 
RpoE from RseA, research has shown that acid stress may also result in the same. It 
was found that mutants deficient in RpoE activity showed increased susceptibility to 
acid and reduced ability to survive inside macrophages. The RseP domain was 
required for this response to the acid shock, but its proteolytic activity was not 
dependent on DegS [44]. It is proposed that the acidic milieu affects the interaction 
between RseB and RseP, which normally keeps RseP inactive, so that RseP is 
released to act on RseA to discontinue negative control over (JE [44]. Both DegS and 
RseP have cytoplasmic and periplasmic domains, and the acid response appears to 
be independent of the envelop stress response. Again, the strength of the response 
is dependent on how much RseB is removed from RseP which in turn depends on 
strength and length of exposure. 
Once (JE is released to interact with RNA polymerase, not all (JE - dependent 
genes are transcribed equally. Within the set of genes transcribed by RpoE, there 
are different promoters with varying levels of affinity for the sigma factor. Within 
the approximately 60 promoters examined that required (JE for transcription, there 
were few very strong promoters (showing high affinity) but many relatively weak 
promoters. The strong promoters were conserved across both E. coli and S. enterica, 
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and were typically involved in maintaining porin homeostasis [45]. Varying 
strength of promoters allow quick and efficient adaptation to different 
environments by being able to transcribe different genes in response to various 
signal [45]. If the stress signal is strong, the cellular concentration of crE will increase 
enough to transcribe at high rates from weak promoters. 
In order to prevent wasted energy and further damage to the cell, the 
activation of crE also results in the downregulation of amp (outer membrane protein) 
mRNA [46]. In this way the cell also prevents these nascent mRNAs from also 
producing misfolded proteins while avoiding destruction by the exocytoplasmic 
stress. Two small non-coding RNAs, Ryb8 and MicA, not under the control of RpoE, 
collectively expedite the destruction of omp mRNAs. Under normal conditions, the 
cellular machinery making outer membrane proteins is still not perfect and some 
misfolded proteins are generated. In this case, the same two sRNAs are involved in 
the response to clear the problem by inducing the crE response, but at a much lower 
level that would be found in a bacteria responding to prolonged stress [46]. As such, 
the two sRNAs are most likely under the transcriptional control of the primary 
sigma factor and their increased activity helps to induce crE -mediated responses. 
As far as specific genes governed by crE, the parts of the crE regulon that are 
highly conserved across species are involved in making the cell wall and outer 
membrane of Gram negative bacteria [47]. The variable portion may be involved in 
the alternative lifestyles that the studied species utilize. A genome wide search was 
done for crE-dependent genes in several species including E. coli and S. 
Typhimurium, determining that several genes were at the core of the crE regulon. 
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Some genes were involved in making lipoproteins, such asy/iO,yeaY, andyraP. 
Others were involved in outer membrane protein synthesis and modification, like 
year, skp,jkpA, and degP. And still others were involved in cell envelope structure, 
such as plsB, bacA, ahpF, andygiM. Interestingly, both rpoE and rpoH were both 
under regulatory control of erE, indicating that erE promotes its own transcription 
and the transcription of other sigma factors [47]. By autoregulation, erE can create a 
multi-fold increase in gene product from its regulon as the extracytoplasmic stress 
sigma factor. All of the genes found to be under the control of erE are related to 
making proteins for cellular structure. 
3.4 erH - Response to Heat Shock 
One of the genes under the transcriptional control of RpoE is another sigma 
factor, RpoH or er32 [47]. This sigma factor has been found to be involved in the 
transcription of genes that help Salmonella withstand high temperatures, potentially 
as a result of fever response within the host. Whereas erE appears to mediate the 
response to misfolded outer membrane proteins, erH seems to be involved with 
proteins within the cytoplasm that are not correct [48]. Concomitant with increased 
heat exposure, cell wall and membrane proteins begin to misfold and denature. As 
the concentration of erE increases in response to the proteins that are misfolded in 
the outer membrane, erH also accumulates to respond to a sustained stressor. This is 
supported by the finding that rpoH expression is directly proportional to erE activity 
at temperatures higher than 42°C [49], a temperature at which protein denaturing 
will reach inside the cell. 
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RpoH governs the transcription of genes incudling those encoding proteases 
that allow for the removal and recycling of misfolding proteins within the cytoplasm 
to prevent damage to the cell. For example, an operon composed of opdA andyhiQ 
was found to be immediately proceeded by a consensus sequence for the RpoH 
promoter [50]. While the function of these two proteins is has not been directly 
studied in the heat shock response, OpdA is metalloprotease oligopeptidase A, a 
protease that would be helpful in degrading misfolded proteins. 
Some researchers have also hypothesized that crH is related to RNA 
thermometers, which are other regulatory means for activating and utilizing heat 
shock genes. RNA thermometers are areas of 5'-untranslated region that fold and 
complementary pair in such a way as to block the Shine-Dalgarno (SD) sequence of 
downstream genes [51]. When heated to sufficient temperatures, these areas 
unpair to allow the ribosome access to the SD sequence. A previously undescribed 
RNA thermometer was found within the 5'-UTR of the agsA gene in Salmonella. This 
gene is known to be involved in response to heat shock and has a promoter region 
containing a consensus sequence for RpoH utilization [51]. Withjn the agsA mRNA 
appear to be RNA thermometer sequences [51]. 
In E. coli, a closely related species to S. Typhimurium, the rpoH mRNA itself 
contains RNA thermometers. It appears in this species, the cellular level of the 
sigma factor is controlled by complementary base pairing in the mRNA. Unlike 
other RNA thermometers, the SD sequence in this case is not blocked but the start 
codon is inaccessible to the ribosome and two halves of the ribosome-binding site 
complementary pair at low temperatures [51]. Because of the importance of heat 
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shock in bacteria as a whole, a similar mechanism is most likely at play in 
Salmonella. 
While responding to heat shock is vitally important for survival of the 
bacteria, perhaps a H most important function is to mediate a E regulation of as 
through hfq gene expression. In E. coli, the promoter sequence found upstream of 
the hfq gene was found to be a H -dependent. The same promoter was found in S. 
Typhimurium [48]. When nutrients are scarce, a E appears to up regulate as through 
the increase of a H [48]. 
The product of the hfq gene, HF -I, is important for translation of RpoS. This 
small protein is heat stable and binds to RNA to facilitate translation [52] by 
associating with the ribosome [53]. Several possible mechanisms for the manner in 
which the protein encoded by hfq regulated as translation have been suggested, 
including by preventing the interaction of some sort of antisense mRNA or by being 
directly involved in the transcription of rpoS [54]. Most evidence supports the 
assertion that the function of HF -I is as a RNA chaperone after it was demonstrate to 
bring the mRNA and ribosome in correct association for translation [55]. 
3.5 as - Stationary Phase Growth, Response to Stress and Starvation 
The role of this sigma factor, also called a38, is slightly more difficult to define 
than that of RpoE or RpoH. However, it is clear that the function of RpoS is essential. 
The conserved sequence of rpoS across multiple species and within the same species 
found in different geographical areas speaks to its importance. When rpoS genes are 
characterized in clinical isolates, the mutations found are not clonal but rather 
novel, implying that there is some selection against mutants. Even when strains 
61 
demonstrated different abilities to survive certain stresses like exposure to 
hydrogen peroxide, it did not appear to be related to different rpoS genes [56]. 
The number and types of genes that seem to be under transcriptional control 
of as have a variety of functions and respond to a wide variety of lifestyle 
requirements and threats to survival. The only known constant about the genes 
transcriptionally governed by RpoS is their dependence on growth phase [57]. 
Previously, work has determined that during logarithmic growth, any activity from 
as promoters is repressed by cyclic-AMP receptor activity [58]. Stationary phase 
growth is characterized by a lack of cellular multiplication and decreasing cell 
density. The transition from exponential growth to stationary phase growth is the 
result of the concentration of a regulatory protein [59]. The concentration of Fis 
(factor for inversion stimulation) a DNA binding protein, is high during exponential 
growth and low in stationary phase. Fis binds to a region of DNA upstream of the 
rpoS promoter and with decreasing amount, allows a switch to stationary phase 
[59]. 
A genome-wide search has been done for genes under the transcriptional 
control of RpoS. The project found that like RpoE, the as regulon includes promoters 
of various strengths. Despite the assumed similarities between the E. coli and S. 
Typhimurium genome and therefore the as regulon, there were several genes within 
the Salmonella genome that were not homologous with any genes of E. coli, which 
may speak to different lifestyles. Several genes of unknown function were found 
under the control of as as well as ogt, which encodes for the enzyme 0 6 -
methyl guanine DNA methyltransferase [58]. This enzyme is responsible for 
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repairing DNA damaged by alkylation. These results supported previous findings 
that bacteria lacking a functional rpoS gene also cannot withstand DNA damage by 
alkylating agents [60]. 
as also seems to playa role in a wide variety of other functions that ensure 
the survival of the bacteria, such as protection from acid shock and nutrient 
depletion. Decreased pH unfolds the secondary structure stem and loops of the rpoS 
mRNA, allowing availability for translation [61]. With increasing pH, RpoS was not 
degraded by proteolytic activity typical of protein turnover, but rather held inactive 
by complementary basepairing rendering the mRNA inaccessible to the ribosome 
when the acid threat had subsided. Constitutive degradation of the sigma factor 
coupled with the lack of more protein being translated resulted in the system reset 
after the acid threat had passed [61]. This is in contrast to previous work which 
concluded that the protein MviA was responsible for responding to the acid shock 
by increasing as level by preventing its degradation. In this work, lacking a 
functional mviA gene resulted in overproduction of as and as - dependent 
transcriptional units and increased tolerance to acid [62]. These two studies 
examined bacteria in different stages of growth, one in logarithmic and one in 
stationary, and potentially two different regulatory pathways are at play dependent 
on growth phase. 
The RpoS sigma factor also seems to be involved in survival of the bacteria in 
nutrient depleted conditions. as has been found to act as both a positive regulator 
for stiA and stiC and a negative regulator for stiR. These three genes are part of the 
multiple-nutrient starving inducing loci. as was required for phosphate, carbon, and 
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nitrogen starvation survival through induction of stiA and stiC. (Js also acted as a 
negative regulator of stiR during starvation-induced stationary growth [63]. 
3.6 (JF - Flagellar Formation and Chemotaxis 
Flagellar assembly was originally assumed to be under the control of (J70 
because it seemed essential to survival. However, examining promoters of known 
flagellar genes found no consensus sequences for (J70 [64]. Instead, researchers 
found promoter sequences in Salmonella known to be used by alternative sigma 
factors in closely related species [64]. (JF, more commonly called FHA or (J2B, has the 
most specific function of all the alternate sigma factors. FHA is involved in the 
transcription of genes related to the formation of flagella, specifically the formation 
of the flagellar filament [40]. Operons of flagellar assembly are proceeded by one of 
three classes of promoters, class 1,2, or 3 [65], [66], [67], which allow for a 
temporal regulation of expression of gene products. From these operons, more than 
50 flagellar genes are transcribed [21]. 
There is only one class 1 operon which encodes the flhD andflhC genes [66]. 
Class 1 is the master opeon, with FlhD and FlhC acting as a global regulator of 
flagellar assembly [67]. FlhD and FlhC form a heterotetrameric complex that is a 
positive transcriptional activator of class 2 promoters through (J70 by interacting 
with the a subunit of the core enzyme [65], [68], [69]. Class 2 operons include genes 
for the assembly of the hook and basal body complex (HBB), (JF, and FlgM [65]. The 
basal body, including the motor, penetrates the cell membrane and includes the 
hook element on the extracellular side ofthe cell [69]. The filament protrudes from 
the hook into the extracellular matrix and turns to provide motility. 
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The third class of flagellar operons requires FHA for transcription [49]. 
Proteins generated from these operons are for the flagellar filament, the generation 
of motor force, and chemotaxis [67]. FlgM which is also transcribed from class 2 
operons along with FliA acts as an anti-sigma factor, keeping FHA inactive until the 
completion of the HBB. The C-terminal ofFliA has a binding site for FlgM [21]. By 
binding to FHA, FlgM prevents RNA polymerase core enzyme from interacting with 
FliA to transcribe class 3 flagellar operons [71]. The FlgM protein is able to assess 
the functionality and completion ofthe HBB because the protein itself is an exported 
substrate [72]. Decreasing cellular concentrations of FlgM release FliA to interact 
with the RNA polymerase core enzyme and transcribe class 3 operons for 
completion of the flagellar filament [72]. The relative concentration of FliA to FlgM 
determines the number of flagella that a single cell will have [73]. Additionally, the 
FlhD /FlhC complex may assist FliA in associated with the RNA polymerase [73]. 
FlhD is involved in assessing nutrient state [74], which may make it necessary to 
more or less mobile. Flagellar formation happens at a specific time during the cell 
cycle, particularly right before the cell divides when the cell is at its largest and the 
intracellular concentration of FlgM before exportation is at its lowest [73]. 
The intracellular concentration of FliA and FlgM is governed by other 
regulatory mechanisms as well. The genes from both of these proteins can be 
transcribed from either class 2 or class 3 promoters [75]. In this way, FliA can 
positively and negatively regulate its own intracellular concentration dependent 
upon the concentration of FlgM within the cell [76]. Over production of flagella is a 
waste of valuable resources [77]. Mutants lacking FlgM make too many flagella and 
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overexpress from class 3 operons [77]. Multiple promoters for genes needed in the 
same cellular process allow for response to environmental conditions as well as 
temporal regulation to avoid excess expenditure of energy by the bacteria [65]. 
4. Changing Sigma Factor~ 
The presence of alternate sigma factors has been well studied, but how do 
the alternate sigma factors displace the housekeeping sigma or each other to govern 
gene transcription? Most of the answer points to concentration dependence; that is, 
the concentration of a particular sigma factor changes in response to different 
environmental conditions. For example, RpoE is expressed constitutively but held 
inactive by various other proteins until an extracellular signal is received. This 
signal activates a series of proteolytic activity that gradually increases the 
intracellular concentration of RpoE. Once RpoE is released, it is free to interact with 
the core enzyme. RpoE is positively auto regulated and as genes are transcribed 
from RpoE promoters, the intracellular concentration increases exponentially so 
that RpoE can outcompete other sigma factors for binding access to the core 
enzyme. RpoE in turn allows for transcription of rpoH, which summarily mediates 
rpoS expression, so that the intracellular level of all three alternative sigma factors is 
increased. Fine tuning of these concentrations allows for precise control of gene 
expression. If a finite amount of RNA polymerase is available, increasing the 
presence of one sigma factor can repress expression of genes requiring a different 
sigma factor [78]. 
Growth phase also appears to playa role in the intracellular concentration of 
certain sigma factors. During exponential growth, intracellular concentrations of (J70 
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remain relatively constant and as is basically absent [79]. During stationary phase 
growth, the intracellular concentration of as increases to nearly 30% of a70 
concentration [79]. Moreover, the concentration of the core enzyme decreases 
during stationary phase growth [79], meaning that a 30% increase in concentration 
is more than a 30% increase in competitive advantage. RpoS activity is repressed by 
uspA and uspB, which are both under the transcriptional control of a70 [78]. During 
exponential growth, as is highly unstable [79]. In stationary phase growth, as is 
released and free to interact with RNA polymerase core enzyme. Researchers have 
hypothesized that there may be a a70 anti-sigma factor under transcriptional control 
of as or that a change in the cytoplasm may favor as - mediated transcription [78], 
allowing the intracellular concentration of as to increase and guarantee more 
interactions with RNA polymerase core enzyme. Most genes expressed during 
exponential growth are not expressed during stationary phase growth, so a70 
proteins need to be rendered inactive [79]. Interestingly, the intracellular levels of 
as reach those of a70 during osmotic shock [63], indicating that the concentration of 
a sigma factor can be a gradual or dramatic depending on the gene expression 
required to survive a particular situation. 
Environmental conditions can also playa role in the stability of the proteins 
which can affect transcriptional efficiency. For example, RpoH, the heat shock sigma 
factor, is high unstable at low temperatures but above 42°C intracellular 
concentrations will transiently increase [79]. Higher temperatures may provide 
increased efficiency of a H - mediated transcription or they may stabilize the protein 
itself so that it is able to interact with the core enzyme [79]. 
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With the idea of differential gene expression through alternate sigma factors 
in mind, it is possible to see how Salmonella is able to respond quickly and 
efficiently to a wide array of environmental conditions inside its host and elsewhere. 
But the picture is not complete without an understanding of the lifestyle of 
Salmonella to provide insight into the phenotype resulting from the differential gene 
expression. 
5. Salmonella as a Pathogenic Bacteria 
In determining how alternate sigma factors are able to promote survival and 
spread of Salmonella, it is important to understand how Salmonella infects its hosts 
and how it avoids attempts by the host to eliminate its threat. Typically, genes are 
discovered that are related in some way to the survival of the pathogen and then 
later research is required to reveal how the transcription of the particular gene is 
controlled. Research involving Salmonella has found that transcription control 
through alternate sigma factors provides an elegant means of balancing gene 
expression and energy usage with pathogenic requirements. By examining 
phenotype and then determining the underlying genotype, researchers have been 
able to determine how Salmonella is able to lead a pathogenic lifestyle. 
Salmonella typically enters its host through the oral route. If sufficient 
numbers are ingested, some organisms will survive the low pH conditions of the 
stomach to reach the small intestine [17]. Sometimes the bacterial infection is 
halted here. For a systemic infection to occur, the bacteria must invade the gut 
epithelium [80]. Salmonella preferentially invade epithelial cells in the distal ileum 
of the small intestine by adhering to and then injecting effector proteins into the 
68 
host cell [81]. The small intestine provides an environment of near-neutral pH and 
high osmolarity, condusive to bacterial invasion not found in the large intestine [82]. 
Within the small intestines, Salmonella specifically invades Peyer's patches 
through M cells. Peyer's patches are specialized lymphoid tissues that are designed 
to sample intestinal antigens and lead to immune responses [83]. Salmonella 
exclusively enter M cells which are found within the follicle-associated epithelium of 
Peyer's patches [84]. M cells are epithelial cells responsible for the uptake of 
luminal antigens [83] and can engulf large particles, making them ideal for target by 
Salmonella [68]. When one bacterium makes entry into the host epithelial cell, it 
recruits other pathogens to its location [85]. 
Not all Salmonella infections spread from the gastrointestinal tract into the 
rest of the host's body, causing a systemic infection. However, if the infection is to 
become systemic, the bacteria must be able to spread and colonize beyond the small 
intestine. The presence of the pathogen in M cells causes damage to the integrity of 
the epithelial cells allowing for dissemination. Salmonella presence in the M cells 
becomes cytotoxic within an hour of infection [84]. In this way, Salmonella is able to 
disrupt barriers between cells to allow for migration [86]. The death of these M 
cells causes gaps to form in the surrounding epithelial tissue, allowing the bacteria 
to spread laterally along the basal lamina or deeper into the follicle [84]. From this 
point, the bacteria can spread through the bloodstream and lymphatic system to 
mesenteric lymph nodes and other deeper tissues [17]. Eventually through the web 
of pathways in the vascular and lymphatic system, the bacteria is transported to 
other organs in the body where it can lay dormant or undergo further replication 
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[17]. It most commonly reaches the lymph nodes, liver, or spleen [87]. Induction of 
inflammation around the initial site of infection results in the recruitment of more 
immune cells and causes diarrhea which can allow the spread of the bacteria to 
other hosts and other environments [82]. 
The travel of Salmonella through different cell types is governed by the 
bacteria's ability to induce it's own internalization into non-phagocytic cells [88], 
[83]. This process is contact mediated and begins when the bacteria touches 
epithelial cells of the small intestine. Salmonella contact with host cells causes 
changes in the host cells' plasma membrane [89]. The bacteria are able to induce 
degradation of microvilli and the formation of cytoplasmic projections from the host 
cell to surround and enclose the bacteria in membrane-bound vesicle [84]. The host 
cells responses to the bacteria appear to be localized, limited to the areas of contact 
between the bacteria and the host cell [88]. The complete internalization ofthe 
bacteria seems to require the adherence of the bacteria cell to the host cell. 
Salmonella has evolved a mechanism that uses components of the host cell's cellular 
machinery to result in its internalization into the cell, specifically the epidermal 
growth factor receptors [88]. 
This induced internalization by host cells is not limited to a specific cell type 
but has been found to occur in all types of eukaryotic cells [89]. Because the 
invasion mechanism is not cell specific, a candidate process would have to be 
present in all eukaryotic cell types. Fimbrial genes are transcribed from several 
operons, each with different fimbrial types [90]. Fimbrial proteins may guide the 
bacteria to the epithelial cells based on certain molecules present on the surface of 
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the eukaryotic cells and different fimbrial types may target bacterial cells to 
different cell lines [90]. 
The ability to be internalized by non phagocytic cell is one distinct 
characteristic of Salmonella. The other hallmark of a Salmonella infection is the 
ability to survive and replicate inside phagocytic cells like dendritic cells and 
macrophages [80], both of which are present in large quantities in the Peyer's 
patches [91]. In fact these cell types seem to rapidly migrate to the area of invasion 
as soon as the bacteria attaches to the epithelial cells [86], a phenomenon not 
observed with commensal E. coli. Some researchers suspect that the bacteria 
stimulates the host cell to release transcellular chemical signals that cause the mass 
migration [86]. Because of the necessity these bacteria have to evade the immune 
system by surviving in phagocytic cells, this mechanism may have evolved to allow 
the bacteria to gain access to macrophages and dendrites before an immune system 
response can be mounted. 
While both dendritic cells and macrophages are important components of the 
host immune system, the lifestyle of Salmonella inside each is different. While inside 
macrophages the number of bacterial cells increases dramatically, there is no 
change in the number of bacterial cells inside dendritic cells [92]. Logically, this 
difference may be based on the different functions of dendritic cells and the 
macrophages within the host immune system. In fact, the ability of Salmonella to 
colonize a particular species may be mediated by the ability to survive within 
dendritic cells of that host [93]. 
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6. The Immune System Response 
At each step in colonization of different cell types, Salmonella are faced with 
an onslaught of attempts by the host's immune system to eliminate the bacteria. 
Host immune systems are able to mount two types of immune responses against 
bacterial invasion: constitutive and inducible [94]. Constitutive defenses include 
barriers like the mucosal epithelium. They are typically present only at the area of 
exposure and the destruction is direct only at the invading pathogen [94]. Also 
included in constitutive immune responses is gastric acidity, which has long been 
considered as a way to prevent ingested microorganisms from migrating out into 
the rest of the body [95]. Typically, the pathogen is ingested along with food or 
water which is by comparison to the conditions inside the host body, lower 
temperature, more neutral pH, and lower nutrient content [83]. As it travels 
throughout the host, the pathogen faces reduced pH in the stomach then higher pH 
in the small intestine and higher concentration of bile salts than in the stomach [83]. 
Other immune responses are induced upon infection. Major targets of the 
innate immune system are pathogen-associated molecular patterns (PAMPs). The 
recognition of these PAMPs result in uptake by dendritic and phagocytic cells [94]. 
Just as Salmonella has evolved a mechanism to get inside nonphagocytic cells, these 
bacteria have also acquired the ability to survive inside phagocytic cells that help 
the innate immune system eliminate them from the host body. 
Dendritic cells transfer information about the bacterial pathogen to the 
adaptive immune system by recognizing PAMPs and capturing and degrading 
bacteria to be presented to T cells [81]. As such, inference with this mechanism 
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promotes bacterial survival [81]. Bacteria bypass the typical processes within 
dendritic cells to prevent presentation of antigens to T cells. Adaptive immunity to 
Salmonella requires B cells and T cells primed by mature dendritic cells [96]. The 
bacteria is enclosed inside a vacuole within the dendritic cell called a Salmonella 
containing vacuole (SCV). Usually, the dendritic lysosomes fuse with vesicles 
containing engulfed pathogens inside the cell, degrade the bacteria, and present 
various pieces to T cells [81]. Inside the dendritic cells, Salmonella restricts 
expression of genes that produce proteins recognized as PAMPs to the inside of the 
cell, preventing dendritic cell maturation, and antigen presentation [96]. 
7. Islands of Pathogenicit}' 
Virulence factors are properties of the pathogen that allow it to invade and 
infect a host [83]. These include genes encoding products that would allow 
Salmonella to enter epithelial cells and survive in macrophages and dendritic cells. 
An estimated 5-10% of genes within the Salmonella genome can be considered 
virulence genes [83]. Some of these genes have been found arranged in clusters 
within the Salmonella chromosome, called Salmonella Pathogenicity Islands (SPIs). 
It has been theorized that these gene clusters were acquired by horizontal transfer 
due to the higher G-C content that in other parts of the Salmonella chromosome [83] 
and similar regions are not found in closely related commensal species such as E. 
coli [89]. There are at least five known SPIs, but SPI-1 and SPI-2 are known to playa 
role in the initial phases of infection. Both SPI-1 and SPI-2 encode type III secretion 
systems (TTSS), although they perform different functions [97]. Additionally, genes 
within the SPIs encode both effector proteins and regulatory proteins [80]. These 
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two secretion systems allow the insertion of effector proteins into both the 
extracellular environment and the host cell. 
In general, SPI-l appears to contain genes involved in bacterial uptake by the 
host cell, while SPI-2 genes contribute to survival inside cells [98]. However, there 
is some evidence that SPI -1 may also be important for life inside the vacuole for 
intracellular replication [99]. Some gene products of SPI -1 physically link the TTSS 
to eukaryotic cells by being injected into the plasma membrane, and recruiting other 
host cell factors to allow internalization [100]. Secreted proteins from genes 
transcribed from SPI -1 leads to actin cytoskeleton rearrangements of the host cell 
that bring the bacteria into the cell in a membrane bound vesicle [101]. SPI-l genes 
include those for effector proteins that trigger signal transduction pathways within 
the host cell to promote the internalization of the bacterial cell. A variety of host 
functions can be hijacked to serve the bacteria's purpose, including cytoskeleton 
arrangement, vesicular trafficking, cell cycle progression, and programmed cell 
death [98]. SPI-l effector proteins activate GTP-binding proteins such as Cdc42, 
Rac-l, and Rho, which coordinate intracellular activities in the host cell [101]. Once 
the bacteria has been brought inside the cell, the actin rearrangement must be 
reversed to enclose them. This is done through other effector proteins that 
down regulate actin rearrangement [102]. 
An important series of proteins called Salmonella invasion proteins (Sips) are 
intimately involved in the ability of the bacteria to induce the host cell to internalize 
it and are found in the SPI-l gene clusters. These proteins are translocases required 
for the intimate association of bacteria with host cells [98]. SipD is found on the 
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bacterial surface prior to contact with the host cell, and may act as a sensor of 
appropriate host cells to invade [98]. SipA does not cause the membrane ruffles in 
the epithelial cells associated with the internalization [103], but mutants with 
deficient sipA genes create ruffles that are not preferentially located at the site of 
bacterial contact [104]. Evidence is mounting that SipA mediates the actin 
rearrangement that allows for the internalization bacteria [104]. SipB and SipC are 
found on both host cell and bacteria after contact has been made [98]. SipC, works 
independently of host cell function, by bundling actin filaments into cables to allow 
for rearrangement favorable to the entry of bacteria [105]. SipC performs functions 
similar to those found within eukaryotic cells, but show no primary similarity with 
eurkaryotic proteins with similar function [105]. 
Another group of important Salmonella proteins are the invasion proteins. 
When delivered orally, bacteria with missing or incomplete invasion regulons are 
unable to colonize the small intestine or the spleen [106]. However, when delivery 
is through a method other than oral, these strains are able to establish infections in 
both of these organs, indicating that these gene products may be essential for the 
establishment of infection after oral exposure to the bacteria [106]. 
Transcription of all SPI-l operons is activated by a regulatory loop beginning 
with HilA [107]. Through other regulator proteins like HilC, HilD, and InvF, 
expression of invasion genes is modulated by HilA [87]. Interestingly, a rising 
concentration of acetate in the distal intestine can activate the expression of HilA by 
bypassing normal positive regulators of expression [82]. The bacteria has evolved a 
mechanism to increase expression of its invasion proteins when in the right place. 
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While SPI -1 may playa role in the procession ofthe infection past the initial 
invasion of epithelial cells, SPI-2 is vital for the migration of bacteria to other parts 
of the host [108]. SPI-2 was the second pathogenicity island discovered and is 
required for survival after bacteria has entered epithelial cells [97]. Mutants 
without SPI-2 genes can enter Peyer's patches but were unable to spread to 
mesenteric lymph nodes [109]. It also appears evolutionarily speaking that SPI-2 
was acquired after SPI-l. The ability to spread and survive past the epithelial tissue 
of the small intestines allowed the expansion of the ecological niche of Salmonella 
[109]. Not all members of the SPI-2 pathogenicity island are equally vital for the 
ability of the pathogen to establish systemic infection. Mutants with various genes 
knocked out show a varying level of attenuation [109], [110]. However, the genes 
within the SPI-2 are responsible for avoiding destruction by lysosomes within 
dendritic cells and macrophages [111]. Expression of SPI-2 genes seems to be 
induced by the slightly acidic conditions inside the initial vacuole formed when the 
bacteria is internalized by the host cell [108]. 
8. Regulation of Salmonella Pathogenicity Islands by Sigma Factors 
Regulatory control of SPls can be exerted by sigma factors. SPI -1 genes are 
typically transcribed using Ecr70 . crH mediates SPI-1 expression by regulating 
activators of SPI-l. Systems mediated by RpoH negatively relate HilD 
posttranslationally and HilA transcriptionally [108]. HilD is responsible for 
activating HilA transcription, and HilA in turn activates all the genes within SPI-1. 
crH directs the production of Lon protease which specifically degrades HilD [108]. 
Through modulating the activating of crH, the bacterial cell can control SPI-1 
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expression. This ensures that SPI -1 expression can be restricted to specific regions 
within the cell [108]. Moreover, as a H is usually used for transcription in the event 
of some stress to the bacteria, the expression of genes from a H, such as Lon protease, 
can restrict the expression of SPI -1 genes during stress. In this way, the cell can 
repress invasion genes long enough to replicate, escape, and invade a new 
macrophage before cell death [91]. 
Promoters for SPI-2 genes all have consensus sequences for a70 [112]. 
However, upstream of some of the genes seemed to be consensus sequences for a E 
that researchers assume may be functional but non-canonical a E binding sites [96]. 
Researchers postulate that these a E binding sites may serve a couple of different 
purposes. The a E - recognized promoters may allow the bacteria to expression TTSS 
in response to host factors that compromise the bacterial cellular integrity [112]. 
Alternatively, a E may fine-tune the expression of SPI-2 genes through a70 [112] by 
preferentially overexpressing certain genes while all others are expressed at basal 
levels by a70 . 
Stationary phase Salmonella are unable to cause the actin rearrangement in 
host epithelial cells that is necessary for entry [85]. Invasion factors are either not 
functional or not expressed in stationary phase bacteria [85]. As growth phase has 
been demonstrated to change intracellular concentrations of different sigma factors 
and virulence genes do not appear to be under the transcriptional control of as,it 
stands to reason that these bacteria would not be able to invade as they are not able 
to expression invasion genes because the activity of the necessary sigma factors is 
repressed. 
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9. Other Genetic Sources of Virulence 
Virulence genes contained outside Salmonella Pathogenicity Islands 
contribute to host colonization and are regulated by sigma factors. Once outside 
the mammalian small intestine, invasion loci are not necessary for spread and 
nutrients are usually limited. For example, the location of the Spv regulon varies 
among Salmonella species from the chromosome to a plasmid, yet all species carry 
the genetic locus, which contributes to intracellular growth once bacteria has spread 
outside of the small intestine [33]. The dependence on the alternate sigma factors 
for the expression of these genes is illustrated by the inability of as mutants to 
efficiently express the Spv regulon. Expression of one of the members of the Spv 
regulon, spvB, was decreased by 86% when as was knocked out [50]. In a functional 
sense, the lethal dosage in mice for a strain without a functional rpoS gene was 1000 
fold greater than wild type [50]. 
The dependence of Spv regulon expression on growth phase also indicates a 
dependence on as for transcription. However, it seems to be nutrient availability, 
not cell density, that is most important in mediated Spv regulon expression [33]. as 
associated with RNA polymerase results in expression of genes that are essential to 
help the bacteria survive nutrient depleted conditions, such as those found in 
deeper tissues beyond the small intestine [33]. 
as increases expression of spv virulence genes by interacting with SpvR, a 
repressor protein for the virulence plasmid [97]. Competition for RNA polymerase 
between as and 0'70 led to less efficient transcription of spvR from its promoter as as 
has a greater affinity for RNA polymerase than 0'70 but a lower affinity for the 
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promoter for spvR [113]. as affinity for RNA polymerase is enhanced by its 
interaction with Crl, giving it the ability to displace a70 as the preferred promoter 
[114]. The presence of SpvR regulates its own transcription [113] so the lack of 
efficient transcription leads to decreasing cellular levels which lead to the 
derepression of spv plasmid virulence genes. as ensures that enough SpvR is present 
to activate transcription from the spvA promoter, the first gene in the regulon [33]. 
10. A Sigma Factor Cascade Contributes to Survival in Phagocytic Cells 
While Salmonella Pathogenicity Islands allow bacteria to invade host cells, 
the pathogen must also survive the hostile environment within. While differential 
gene expression through various sigma factors ensures the appropriate expression 
of SPIs during access to the intracellular milieu, the use of sigma factors also permits 
subsequent survival. Ferric Fang describes a cascade of transcription and 
translational events that involve sigma factors associating with the core enzyme to 
transcribe genes for each other and those necessary to respond to a variety of 
assaults in the intracellular environment [115]. The first step in the cascade is 
activation of aE'which is constitutively expressed through a70 promoters but held 
inactive by a pair of negative regulators, RseA and RseB [116]. RseA interacts with 
a E in such a way to block the binding site for RNA polymerase [44]. When an 
extracytoplasmic stress is perceived, a E is released by RseA and freed to bind to RNA 
polymerase. Interaction of a E with the core enzyme allows for transcription from 
other promoters. These promoters include those before the a E regulon of genes but 
also before the rpoH gene, which encodes the alternative sigma factor, a H• a H 
provides specificity for RNA polymerase to transcribe genes in the a H regulon, which 
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respond to cytoplasmic stress. Additionally, a H allows transcription of hfq. The Hfq 
protein interacts with the rpoS mRNA to facilitate its translation. The as then allows 
transcription of genes under its transcriptional control, which allow for a starvation 
response [115]. This overall cascade allows for coordinated response by the 
pathogen. To ensure that sigma factors help transcribe genes needed to respond to 
stress only as long as it exists, there must be some mechanism of turnover [115]. In 
this way, the use of an interconnected web of sigma factors allows the Salmonella to 
gain access to various cell types and then survive within the cells to be able to 
spread to other areas of the host. 
This cascade's vital importance to survival in particular within macrophages 
is illustrated by the increased levels of as inside the macrophage following infection. 
Some aspect of being inside a macrophage results in increased transcription of the 
rpoS gene. While levels of the housekeeping sigma a70 decreased, levels of as 
increased about 10 fold a few hours after infection [117]. The conditions inside the 
macrophage induce the stress response and restrict nutrient availability, which 
induces the sigma cascade of gene expression to help the bacteria survive, not 
necessary become virulent. 
11. Sigma Factors Coordinate Gene Expression Together 
Rarely is gene expression controlled in a strictly linear manner. That is, 
multiple sigma factors may work together to fine tune expression of a group of 
genes to provide the bacteria with the high probability of survival. The cascade of 
sigma factors to be able to survive inside phagocytic cells described above is just 
one example. There are many other instances of sigma factors working 
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simultaneously to express a certain suite of genes to allow response to a particular 
stimulus. 
One way to determine if one sigma factor plays a role in the efficient 
transcription by the other is to knock out one of them and see how the function of 
gene products mediated by the other are effected. In this way, researchers 
determined a relation between RpoE and FliA. Mutants without rpoE showed 
defective or limited mobility [118]. In these mutants, expression from class 1 
flagellar promoters remained unaffected while some class 2 and most class 3 
promoters showed decreased activity as compared to wild type [118]. Researchers 
concluded that RpoE may promote expression from class 3 promoters by mediating 
expression of FliA during osmotic stress, such as the hyperosmotic conditions found 
in the small intestine [118]. 
RpoH and RpoN also appear to be related in their ability to control the same 
genes as well as the dependence of one on the other. Expression of some heat shock 
operons appear to be under the control of RpoN in certain conditions, as expression 
from a H operons is down regulated in mutants with rpoN knockout [36]. In this way, 
RpoN may be responsible for fine tuning some gene expression during heat shock 
response. The expression of topoisomerases also appears to be governed by both aN 
and a H [36], which may also indicate an interdependence of the two sigma factors on 
the activity of the other. 
Insufficient expression of one sigma factor can be compensated for by 
overexpression of other sigma factors. For example, inside macrophages while RpoS 
only moderately increased following infection, RpoH and RpoE showed dramatic 
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increases in intracellular concentration [119]. While RpoS is typically associated 
with virulence inside phagocytic cells, it may be possible for other sigma factors to 
express a suite of genes by working together to achieve the same end result. 
Research has also demonstrated that RpoN can compensate for insufficient RpoS in 
the formation of certain lipopolysaccharides [120]. RpoE is able to mediate RpoS 
levels during stationary phase growth through RpoH and the RNA chaperone Hfq to 
ensure appropriate gene expression to respond to diverse stressors [48]. 
12. Survival Outside of a Host 
While Salmonella is an important enteric pathogen as it infects many hosts 
and can be transmitted from species to species, it also is able to survive outside any 
host. Because of this characteristic, it has been an important target of sanitation 
processes to eliminate possible sources of transmission. Unfortunately for food 
service personnel, Salmonella have also evolved a variety of strategies to withstand 
attempts to eliminate them from food sources, some of which have been found to be 
modulated by the use of alternate sigma factors. There are basically three strategies 
to eliminate bacteria in food service: high temperatures, low temperatures, and 
washing. Salmonella has evolved mechanisms to unfortunately survive many of the 
attempts to eliminate it. 
Because Salmonella can infect a variety of hos~s, one means of transmission 
to human hosts is through food products that are infected themselves, such as 
poultry. The same mechanisms of alternate sigma factor used to survive acid 
challenges in a mammal gut are also utilized in surviving the fowl gastrointestinal 
tract and can lead to transmission of the pathogen to a new host [121]. 
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Other studies specific to food handling procedures and alternate sigma 
factors have determined that RpoS, for example, is essential to Salmonella's ability to 
withstand normal sanitation procedures common in the food service industry and 
that early induction of RpoS can cause the cells to enter stationary growth phase 
prematurely, negating the protective nature of stationary growth to the pathogen's 
ability to survive [122]. Other studies have demonstrated that certain food handling 
processes, such as washing in various antimicrobial agents, can induce RpoS to 
protect the bacteria from destruction [123]. Significant drops in temperature have 
also been found to activate transcription from ers dependent promoters rather than 
from the er70 promoters from which genes are normally transcribed, indicating that 
ers may help the organism survive in cold temperatures [124]. 
Sometimes multiple alternate sigma factors contribute to survival through 
food processing. For example, erS and erE were both found to be important in 
surviving refrigeration and changes in osmotic pressure. Depending on the nature 
of the stress, either ers or erE may be more important and their relative concentration 
dictated the type of response [125]. In short, Salmonella employs the same 
strategies to survive food processing as it does to survive changing environmental 
conditions inside its host. 
13. Regulation of Sigma Factors 
Because sigma factors are capable of dramatic changes in cellular protein 
composition and energy use, their effects must be closely guarded to ensure that the 
pathogen is responding to the stress without exhausting cellular resources. Some 
alternate sigma factors are constitutively expressed but held inactive until they are 
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needed by regulatory proteins that change conformation or leave the cell in 
response to a particular signal. For example, RpoE is held inactive until an 
extracellular signal of extracytoplasmic stress is received and FliA is held inactive by 
FlgM until the FlgM is exported out of the cell by the completed hook and basal body 
structure. Some regulation of sigma factors is accomplished by the optimal 
conditions under which they can influence gene expression. For example, rpoH can 
not be translated below a certain temperature because at lower temperatures the 
mRNA folds back on itself blocking the start codon. And RpoS shows increased 
efficiency at stationary phase growth and is almost nonexistent during exponential 
growth, potentially due to a change in the intracellular milieu caused by a different 
growth stage. 
Because much of the efficiency of sigma factors to influence transcription is 
influenced by their relative concentrations within the cells, many mechanisms to 
regulate them change the available concentration of these proteins. Different 
proteases target specific sigma factors and depending on the relative concentration 
of these proteases, the relative availability of the sigma factors can be adjusted. As 
the concentration of core enzyme is constant, this can dramatically effect gene 
expression. 
Because of the wide variety of genes under its transcriptional control and the 
ability of RpoS to elicit a strong response, its activity must be closely monitored by 
the bacteria. Several novel pathways of regulation have been discovered, and it is 
almost certain that others exist. DksA is required for efficient translation of rpoS but 
not at the same location as the protein product of hfq [126]. Another protein, RstA, 
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decreases the expression of RpoS controlled genes and appears to decrease cellular 
levels of RpoS independently of proteolytic activity [127]. Translation of the rpoS 
mRNA is elevated in the presence of appropriate carbon sources, indicating a 
growth rate dependent control of sigma factor availability [38]. In response to 
increased glucose levels, StpA prevents overactivation of as indirectly enhancing its 
turnover [128]. Some small mRNAs such as DsrA and RprA, are highly conserved as 
are their antisense elements within the rpoS mRNA but only have small effects on 
RpoS availability [129]. DsrA interaction with rpoS mRNA disrupts the stem and 
loop base pairing of rpoS mRNA to allow high levels of translation [130]. The same 
study discovered another small RNA, RprA, that interacts in a similar way to 
positively regulate RpoS translation [130]. The high number of complex regulation 
systems that operate independently of each other speak to the need to be able to 
quickly change RpoS activity as well as to the functions that RpoS helps to mediate. 
14. Sigma Factors and Other Regulatory Mechanisms 
Differential gene expression through alternate sigma factors is far from the 
only regulatory mechanism with Salmonella and there are points in the response to 
environmental stimuli that these other regulatory pathways are influenced by or 
influence alternate sigma factors. Two important regulators that intersect 
differential gene expression with sigma factors are the PhoP /PhoQ regulatory 
system and the Fis global regulator. 
The PhoP /PhoQ regulatory system influences the expression of many genes 
and is functionally a sensor of extracellular magnesium concentration. It has been 
found to have evolved differently in closely related species like E. coli and 
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Salmonella as a result of different lifestyles [131]. The relation between the 
PhoP /PhoQ regulatory system and as appears to be essential. Even in cells with 
functional copies of rpoS, mutants lacking PhoP cannot form functional phagosomes 
within phagocytic cells [132]. Mutants with a double knockout ofthe RpoS and 
PhoP /PhoQ show decreased virulence and decreased invasion of host cells [133]. It 
has even been suggested that because of their inability to cause lasting infections, 
these double knockouts should be used to make a Salmonella vaccine [133]. 
PhoP controls the level of available RpoS by controlling proteins which 
enable its degradation by ClpXP. PhoP acts as a transcriptional activator for iraP, 
which encodes for a protein that interacts with RssB. RssB facilitates ClpXP 
degradation of as [134]. By blocking RssB activity, the level of as accumulates 
during PhoP /PhoQ activation, which includes low levels of magnesium as found 
inside macrophages. This is very different than the type of regulation seen in the 
commensal E. coli [134], indicating that while there is some similarity in the genes 
expressed between the two, the regulation of the alternative sigma pathways is not 
the same. 
Interestingly, RpoE seems to be involved in the regulation of PhoP /PhoQ 
activity through Hfq, the same RNA chaperone through which it mediates RpoS 
expression [135]. As RpoE is at the top of a cascade that leads to increased RpoS 
concentration, it stands to reason that there would be a multitude of ways through 
which RpoE regulates RpoS level. 
Fis (factor for inversion stimulation) is a global transcription regulator and 
facilitates site-specific DNA recombination [136]. The intracellular concentrations 
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of Fis are high during exponential growth and low in late exponential and stationary 
phase growth [137]. The fis promoter itself is of some interest into how these 
concentration differences are maintained. It is a70 dependent and growth-phase 
dependent regulation from this promoter is achieved through a weak -35 sequence, 
a second RNA polymerase binding site, and the relative concentration of nucleotides 
within the cell [138]. The fis promoter is somewhat unique among a 70 - dependent 
promoters in that transcription begins with a cysteine [137]. This residue is 
normally a poor initiator of transcription and as a result the RNA polymerase 
holoenzyme binds very weakly with the fis promoter [137]. When cellular 
concentrations of cysteine are low, there is very little transcription from the 
promoter but as CTPs increase in the cell, so does gene expression from the fis 
promoter [137]. 
As expected from the pattern of Fis concentration in the cell, there is a 
negative relationship between the intracellular level of RpoS and Fis during 
stationary phase growth [140]. Fis in fact is able to mediate expression from as -
dependent genes by binding to a Fis-specific site upstream of as promoter regions 
and blocking RpoS activity during exponential growth [59]. 
Fis, as its name suggests, is also essential for the ability of Salmonella to 
switch flagellar types. There are two types of flagellar filaments, FljB and FliC, 
which are both transcribed from class 3 promoters. Flagellar switching is achieved 
by inversion of a promoter region. When expression occurs from this promoter, a 
type B filament is produced and a repressor of type C is created. When the inversion 
occurs, the repressor of type C is not produced and type C filaments are made [140]. 
87 
Hin (for H invertase) and Fis are both required for proper inversion [141]. Hin 
seems to mediate the inversion while Fis ensures the appropriate alignment of the 
piece of DNA that is being inverted [141]. 
In having two different types of filaments available for use, Salmonella is able 
to evade the host immune system. FliC is a well-studied target ofthe immune 
system [91]. As bacteria migrate through the small intestines and into the rest of 
the host, FliC expression is suppressed or switched for FljB expression to avoid 
detection by T cells [91]. Once past the initial site of infection, T cells are no longer 
able to recognize the pathogen [91]. Fis allows for the switching of promoter 
availability to FliA and due to its pattern of concentration in the cell, ensures that 
the bacteria is not wasting cellular energy making flagella while in stationary 
growth. 
Finally, the relatedness of alternate sigma factors and pathogenicity can 
ensure that certain genes are not expressed at the wrong time. The gene hilA which 
is responsible for the regulation of SPI -1 genes is found in the same operon as FliA, 
the alternate sigma factor for flagellar filament assembly [87]. This proximity 
within the genome allows for the simultaneous control of both mobility and 
invasion properties. 
15. From Theory to Practice 
Differential gene expression through the use of alternate sigma factors is one 
of numerous regulatory methods available to Salmonella to avoid destruction by its 
host's immune system or sanitation processes and to thrive in a variety of 
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environments. Control through sigma factors intersects control exerted by other 
regulatory pathways to ensure a highly controllable pattern of gene expression. 
There is yet much more work to be done in this area. The full capacity of 
Salmonella to change rapidly and accurately to respond to environmental conditions 
is still not well understood. Genes that are central to virulence are often under the 
most types of regulatory control. For example, sigma factor expression is itself is 
highly controlled at the level oftranscription and translation, but they are 
interconnected in a complex web, regulating and fine tuning the gene expression 
from each type of promoter. 
The use of alternate sigma factors seems to be a specific evolutionary tactic 
for Salmonella to survive in the environment and inside a host. The differential gene 
expression that Salmonella demonstrates is induced by environmental conditions 
that the pathogen encounters within its hosts. Moreover, these environmental 
conditions are in a constant state of flux, as a product of the bacteria's movement 
through its host as well as the changing state of the host itself. It is not clear the 
extent of signals that induce the differential gene expression in Salmonella. 
Sensitivities and properties that Salmonella demonstrates outside of a host may be 
quite different from what happens inside another organism. While there is no 
evidence that differential gene expression through alternate sigma factors confers 
antibiotic resistance, it is likely that the adaptive manner in which Salmonella is able 
to survive within its host will affect its interaction with other bacteria grown in the 
same system and the ability of the antibiotic to act on the bacteria by allowing it to 
change phases of growth rapidly as a population. 
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